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Zusammenfassung
Die Alzheimer Erkrankung ist die ha¨ufigste Form von Demenz bei a¨lteren Men-
schen. Die Hauptkomponente der amyloiden Plaques im Gehirn von Alzheimer
Patienten sind die Aβ Peptide, welche durch die Aktivita¨t der γ-Sekretase in den
extrazellula¨ren Raum gelangen. Die γ-Sekretase ist ein multimerer Komplex von ho-
hem Molekulargewicht und besteht aus den Untereinheiten Pra¨senilin (PS), Nicas-
trin, anterior pharynx-defective phenotype 1 (Aph1) und PS enhancer 2 (Pen2).
In einer vorausgehenden Arbeit wurde ein Qualita¨tskontrollmechanismus fu¨r den
Zusammenbau der γ-Sekretase vorgeschlagen. Dieser Mechanismus basiert auf Re-
tentionssignalen, welche die isolierten Untereinheiten und Zwischenformen des
Zusammenbaus im endoplasmatischen Retikulum (ER) halten. Diese Signale wer-
den im korrekt assemblierten Komplex inaktiviert und die γ-Sekretase wird an die
Plasmamembran und in die Endosomen transportiert, wo sie aktiv ist. Das Ziel der
vorliegenden Arbeit war es, Belege fu¨r die vorgeschlagene Qualita¨tskontrolle beim
Zusammenbau der γ-Sekretase zu finden.
Der erste Schritt dieser Arbeit war die Identifizierung von ER Retentionssignalen
in den verschiedenen Untereinheiten der γ-Sekretase. Durch die Anwendung von
Reporterproteinen konnten zwei neuartige ER Retentionssignale identifiziert werden,
welche in der Transmembrandoma¨ne (TMD) 4 von PS1 und der TMD1 von Pen2
liegen. Beide Signale basieren auf polaren Aminosa¨uren im hydrophoben Umfeld
einer TMD. Das Signal in der Pen2-TMD1 tra¨gt außerdem zur Stabilita¨t von Pen2
bei. Die Mutagenese der zwei bekannten Retentionssignale in PS1 (TMD4 und
TMD9) fu¨hrte nicht zum Export von PS1 aus dem ER. Daher ist zu vermuten, dass
es weitere Signale in PS1 gibt, entweder in den verbleibenden 7 TMD oder in den
zytoplasmatischen Bereichen von PS1.
Der zweite Teil der vorliegenden Arbeit zielte auf die Identifizierung von Kom-
ponenten, welche die TMD-basierte ER Retention vermitteln. Retention in the ER
1 (Rer1) wurde als ein Protein identifiziert, das zur ER Retention von Pen2, je-
doch nicht von PS1, beitra¨gt. Pen2 ist das erste bekannte Substrat von Rer1 in
Sa¨ugetierzellen wobei Rer1 mit Pen2 durch die Bindung an die Pen2-TMD1 in-
teragiert. Die Unabha¨ngigkeit des Signals in der PS1-TMD4 von Rer1 impliziert,
dass es weitere bisher unbekannte Mechanismen gibt, welche zur TMD-basierten ER
Retention beitragen.
Als Drittes wurde ein Mechanismus aufgekla¨rt, durch welchen ER Retentionssig-
nale in der assemblierten γ-Sekretase inaktiviert werden. Ergebnisse von uns und
anderen zeigten bereits, dass die Pen2-TMD1 und die PS1-TMD4 notwendig fu¨r
die Interaktion von PS1 und Pen2 sind. Dementsprechend sind beide TMD bifunk-
tional, da sie sowohl zu einer Protein-Protein Interaktion als auch zur ER Retention
beitragen. In der vorliegenden Arbeit konnte gezeigt werden, dass diese Protein-
Protein Interaktion zu einer Maskierung und somit zur Inaktivierung der Retentions-
signale in beiden TMD fu¨hrt. Auf diese Art und Weise sind beide Funktionen der
TMD aneinander gekoppelt. Diese Kopplung kann von der ER Qualita¨tskontrolle
genutzt werden, um den Prozess des Zusammenbaus der γ-Sekretase zu u¨berwachen.
Ho¨chstwahrscheinlich kann dieser Mechanismus fu¨r andere multimere Proteine wie
Ionenkana¨le und Rezeptoren an der Plasmamembran verallgemeinert werden.
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Zusammenfassung
Daru¨ber hinaus wurde hier gezeigt, dass die stabile U¨berexpression der PS1-
TMD4 den beschriebenen Qualita¨tskontrollmechanismus sto¨rt und somit den
Zusammenbau der γ-Sekretase verhindert. Diese Beobachtung hebt die Rolle der
TMD der γ-Sekretase nochmals hervor. Zudem ero¨ffnet sie eine Mo¨glichkeit zur
pharmakologischen Beeinflussung der γ-Sekretase u¨ber ihre TMD, welche genutzt
werden ko¨nnte, um dieses wichtige Enzym bei pathologischen Zusta¨nden zu inhi-
bieren.
ix
Abstract
Alzheimer’s Disease (AD) is the most frequent form of dementia found in the
elderly. The Aβ peptides that are the principal component of the amyloid plaques in
the brains of AD patients are released to the extracellular space by the activity of γ-
secretase. The γ-secretase is a multimeric, high-molecular-weight complex composed
of presenilin (PS), nicastrin, anterior pharynx-defective phenotype 1 (Aph1) and PS
enhancer 2 (Pen2). In previous work a quality control mechanism for γ-secretase
assembly was suggested that is based on retention signals, which keep unassembled
subunits and assembly intermediates in the endoplasmic reticulum (ER). These sig-
nals become inactivated in the properly assembled complex and the γ-secretase is
transported to the plasma membrane and the endosomes where it is active. It was
the aim of the present study to provide evidence for the proposed quality control
hypothesis for γ-secretase assembly.
The first step in this work was the identification of ER retention signals in the
different subunits of γ-secretase. By applying a reporter protein approach, two novel
ER retention signals were identified in the transmembrane domain (TMD) 4 of PS1
and the TMD1 of Pen2. Both signals are based on polar residues in the hydrophobic
context of a TMD. The signal in the Pen2-TMD1 also contributes to the stability
of Pen2. Mutagenesis of the two known signals in PS1 (TMD4 and TMD9) did not
result in the ER export of full-length PS1. Thus, it is suggested here that further
signals exist in PS1, either in the remaining 7 TMDs or in the cytoplasmic domains.
The second part of the present study aimed on the identification of the machin-
ery accomplishing TMD-based ER retention. Retention in the ER 1 (Rer1) was
identified as a protein involved in the ER retention of Pen2 but not PS1. Pen2 was
the first identified mammalian substrate of Rer1 and Rer1 interacts with Pen2 via
the binding to the Pen2-TMD1. The signal in the PS1-TMD4 is independent of
Rer1, suggesting that other, so far unknown mechanisms exist which contribute to
TMD-based ER retention.
Third, the mechanisms by which ER retention signals become inactivated in the
assembled γ-secretase was elucidated. Data from our lab and by others already
demonstrated that the Pen2-TMD1 and the PS1-TMD4 are necessary for the inter-
action of PS1 and Pen2. Thus, both TMDs are bifunctional, since they contribute
to protein-protein interaction and to ER retention. It was shown here, that the
protein-protein interaction between the TMDs results in the masking and inactiva-
tion of the retention signals in both TMDs. In this way both functions of the TMDs
are connected and this mechanism can be used by the ER quality control to probe
the assembly status of γ-secretase. Most likely, this mechanism can be generalised
for other multimeric proteins like ion channels and cell surface receptors.
Furthermore, it was shown that the stable overexpression of the PS1-TMD4
interferes with the described quality control mechanism and thus with the assembly
of the γ-secretase. This finding highlights the relevance of TMDs for γ-secretase
function and it discloses the possibility that pharmacological targeting of γ-secretase
TMDs could be used to inhibit this important enzyme under pathological conditions.
x
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Introduction
1.1 Alzheimer’s Disease
1.1.1 Relevance of Alzheimer’s Disease to modern societies
Alzheimer’s Disease (AD) has been described for the first time in 1906 by Alois
Alzheimer and has been thought to be a special form of presenile dementia. Nowa-
days, it is commonly accepted that dementias of the Alzheimer type are the most
frequent form also of senile dementias (Selkoe, 2001). Early symptoms of AD are
problems in concentration or forgetfulness, which are often considered as normal
signs of ageing. The progression of the disease is accompanied for instance by lan-
guage deterioration, depression, impaired ability to process visual information and
confusion. In the end stage the entire loss of the personality may occur. Due to
the advancing loss of independence in day-to-day situations intensive care for the
patients is necessary.
The risk to develop AD exponentially grows with age, especially after the age of
65, leading to a prevalence of almost 25 % for people older than 85 years in Germany
(Ott et al., 1995; Bickel, 2000). The second most important risk factor after age
is genetic predisposition. Yet, the inherited, familial AD (FAD) accounts only for
less than 5 % of all AD cases (Bertram and Tanzi, 2005). FAD cases are very often
characterised by an early onset before the age of 65 and a fast progression of the
disease. Considering the demographical development the number AD patients in
Germany will increase from 935,000 in the year 2000 to an estimated number of
2,620,000 by 2050 (Deutsche Alzheimer Gesellschaft).
The increasing case numbers in combination with the extensive care needed by
the patients, highlight the necessity to develop a cure or at least a prophylaxis for
AD. Otherwise AD will become a socioeconomic challenge within the next decades.
1.1.2 Neuropathological hallmarks of Alzheimer’s Disease
AD results from a loss of neurons in regions important for memory and learning,
like the neocortex, limbic structures (e.g. hippocampus and amygdala) and some
brainstem nuclei. Ultimately, this neuronal loss results in the severe brain atrophy
observed in the brains of AD patients (figure 1.1A). On a microscopic level three
more hallmarks were identified. The two most prominent ones were already de-
scribed by Alois Alzheimer: Neurofibrillary tangles and senile or neuritic plaques.
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Neurofibrillary tangles are large, intraneuronal bundles of abnormal fibres, which
consist of so-called paired helical filaments. These paired helical filaments are highly
insoluble aggregates of a hyperphosphorylated form of the microtubule-associated
protein tau (figure 1.1B). Neurofibrillar tangles have been also described in other
neurodegenerative diseases (Selkoe, 2001). The second microscopic hallmark of AD,
neuritic plaques, are extracellular deposits of the amyloid β-protein (Aβ). Plaques
have a compact, fibrillary structure and can vary in size between 10 to more than
120 µm (figure 1.1C). The majority of the amyloid β-protein found in the plaques
is the more aggregation prone Aβ42 form. Dystrophic neurites are found within
and immediately surrounding the plaques (Selkoe, 2001). Third, additionally to
protein aggregates visible in AD brains, cellular changes have been detected using
immunohistochemistry. The formation of neuritic plaques is intimately coupled to
the activation of an inflammatory response resulting in microgliosis and astrocyto-
sis(figure 1.1D)(Weiner and Frenkel, 2006).
A B
C
D
Figure 1.1: Pathological hallmarks of Alzheimer’s Disease. A) Brain atrophy. Nor-
mal brain (top) and AD patient brain (bottom). Picture from PEIR digi-
tal library. B) Neurofibrillary tangles. HE staining. C) Neuritic plaques.
Bielschowsky silver stain. Pictures B) and C) from WebPath: The Inter-
net Pathology Laboratory, 2009. D) Microgliosis in APPPS1-21 transgenic
mouse model. Iba-1 immunostaining and Congo red staining in the neocor-
tex of an 8 month old APPPS-21 mouse. Iba-1 positive microglia clustered
around a plaque. Scale bar 20 µm. Picture from Radde et al., 2006.
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1.2 Molecular basis of Alzheimer’s Disease
Although hereditary forms of AD comprise only a small fraction of all AD cases,
they have provided great insight into the molecular processes underlying Alzheimer’s
Disease. So far 200 mutations were identified that lead to FAD (Alzheimer Disease
& Frontotemporal Dementia Mutation Database). All mutations were identified
within only 3 genes: APP, PSEN1 and PSEN2 (Bertram and Tanzi, 2005). APP
encodes the β-amyloid precursor protein and PSEN1 and PSEN2 encode presenilin-1
(PS1) and presenilin-2 (PS2), respectively.
In addition to mutations that ultimately cause FAD several susceptibility genes
were identified that lead to a late onset AD. The best studied is the apolipoprotein E
(APOE) genotype, with the 4 allele being an AD risk factor and the 2 allele being
protective (Corder et al., 1993; Strittmatter et al., 1993). More recently, genome
wide association studies revealed further genetic risk factors for AD which were inte-
grated into the AlzGene database (Bertram et al., 2007). Among these susceptibility
genes are for instance angiotensin I converting enzyme 1 (ACE1), cholesterol 25-
hydroxylase (C25H) and the nicotinic acetylcholine receptor β2 subunit (CHRNB2)
(Bertram et al., 2007; Bertram and Tanzi, 2008).
1.2.1 The β-amyloid precursor protein (APP)
Biochemical analysis of the neuritic plaques in AD patients postmortem brains
led to the isolation and partial sequencing of Aβ in the 80s of the last century
(Glenner and Wong, 1984; Masters et al., 1985). Using this information the APP
gene cloned shortly thereafter in several laboratories (Kang et al., 1987; Goldgaber
et al., 1987; Tanzi et al., 1987). The localisation of the APP gene on chromosome
21 was consistent with the finding of an AD pathology in middle-aged patients
with Down syndrome (Robakis et al., 1987). APP is a member of a small and
highly conserved gene family comprised of APLP1 and APLP2 (H. sapiens), Appl
(D. melanogaster) and apl-1 (C. elegans). All encode for large type I membrane
proteins with a large extracellular domain and a short cytoplasmic tail, yet only
APP contains the domain giving rise to the Aβ peptide. Alternative splicing leads
to mainly three different APP isoforms of different length (APP695, APP751 and
APP770). Neuronal APP is almost exclusively expressed as the APP695 isoform
(Kang and Mu¨ller-Hill, 1990). As of today, the most consistently established function
for APP is an autocrine and paracrine role in growth regulation (Thinakaran and
Koo, 2008; Nikolaev et al., 2009).
The APP ectodomain is shedded by α- or β-secretase generating small membrane
bound C-terminal fragments (CTF). αAPP-CTF and βAPP-CTF are an immediate
substrate to several cleavages by γ-secretase which lead to the release of p3 and
Aβ, respectively, into the extracellular space and of the APP intracellular domain
(AICD) into the cytosol (Thinakaran and Koo, 2008)(figure 1.2). α-secretase ac-
tivity was found for several different proteases with zinc metalloproteases of the
ADAM family (A disintegrin and metalloproteinase; ADAM-9, ADAM-10, ADAM-
17/TACE) as the most prominent enzymes (Allinson et al., 2003). α-secretases
cleave APP within the Aβ domain at position K612 and the p3 protein released by
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Figure 1.2: APP is cleaved by α-, β- and γ-secretase. Cleavage by α-secretase initiates
the non-amyloidogenic pathway resulting in the release of p3. In contrast, β-
secretase cleavage initiates the amyloidogenic pathway that ultimately leads
to the release of the Aβ peptides of different length. Both pathways result in
the release of AICD into the cytosol and of the respective sAPP fragments
into the extracellular space (Thinakaran and Koo, 2008).
subsequent γ-secretase cleavage is not aggregation prone. Thus, α-secretase trig-
gers a non-amyloidogenic series of cleavage events. Neuronal β-secretase activity
was demonstrated for BACE1 (β-site APP-cleaving enzyme 1). BACE1 is an as-
partyl protease and a type I membrane protein that cleaves APP at position M596,
thus generating the Aβ N-terminus with D597 as the first residue (Cole and Vassar,
2008). More recently, another cleavage site was postulated in the N-terminal domain
of APP. However, neither the protease nor the functional relevance of this cleavage
was shown (Nikolaev et al., 2009).
FAD-linked mutations in the APP gene were named after the geographical ori-
gin of the affected families (e.g. Swedish, Arctic, London, ...). The found mutations
either increase the propensity of the released Aβ peptide to aggregate or they affect
the proteolytic processing of APP (figure 1.3). For instance, the Swedish double mu-
tation (K595M, M596L) increases the frequency of a β-secretase cleavage, hence the
overall production of Aβ species is increased (Citron et al., 1992). Other mutations
affect the generation of the Aβ C-terminus by γ-secretase, thus the ratio between
the longer Aβ42 and the shorter Aβ40 is increased. Since Aβ42 is more aggregation-
prone whereas Aβ40 was supposed to be an anti-aggregation factor (McGowan et al.,
2005) this causes an increase in the formation of neurotoxic Aβ oligomers (see sec-
tion 1.2.3). Additionally, duplications of the entire APP gene lead to genetically
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Figure 1.3: APP is cleaved at multiple sites and a variety of FAD-linked mutations have
been identified in APP. FAD-linked mutations in APP are depicted in bold
and the TMD region in APP was marked with yellow. βAPP-CTF process-
ing by γ-secretase leads to two product lines generated by stepwise cleavages
at every third amino acid. The different cleavage sites were denominated
with greek letters. The first cleavage at the -site determines which line is
chosen, either from 49 to γ37 or from 48 to γ39. Both product lines do
not necessarily proceed until the last cleavage. Modified after Steiner et al.,
2008a.
determined AD for instance in patients with Down syndrome.
1.2.2 The γ-secretase
γ-secretase is an aspartyl protease that cleaves a variety of substrates within their
transmembrane domains (TMD). As of today, there are more than 60 substrates
known with APP and Notch as the most prominent ones (McCarthy et al., 2009).
γ-secretase is composed of the four subunits Aph-1 (anterior pharynx-defective-1),
Pen2 (presenilin enhancer-2), Nct (nicastrin) and PS1 or PS2. All four subunits
were necessary and sufficient to yield proteolytic activity (Kimberly et al., 2003;
Edbauer et al., 2003) and were found in a 1:1:1:1 stoichiometry within the complex
(Sato et al., 2007)(figure 1.4). Estimation of the size of γ-secretase by native gel
electrophoresis revealed a molecular mass of ∼500 kDa, although the mass of the
individual subunits sums up to approximately 200 kDa (Pen2 ∼12 kDa, Aph-1 ∼20
kDa, PS1/2 ∼50 kDa, mature Nct ∼120 kDa). Schroeter et al., 2003 suggested a
dimerisation of the tetrameric complex to explain the observed differences in the
complex size though these findings are still controversial. Besides the four core
subunits several other proteins were found to interact with γ-secretase and/or to
modulate its activity such as CD147 (Zhou et al., 2005), TMP21 (Chen et al., 2006)
and GPR3 (Thathiah et al., 2009). The detailed assembly of γ-secretase is described
in section 1.5.
Presenilins were the first identified γ-secretase subunits because FAD-linked mu-
tations were discovered in the PS genes (Sherrington et al., 1995; Rogaev et al.,
1995). Presenilins contain 9 TMDs and the N-terminus faces the cytosol, whereas
the C-terminus folds back into the membrane from the lumenal side (Spasic et al.,
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Figure 1.4: γ-secretase is composed of Presenilin, Nicastrin, Aph-1 and Pen2. The
topology of all four essential subunits is shown. The arrowheads indicate the
positions of the catalytic aspartates and the red rectangle the endoproteolytic
cleavage site in PS1/2. The Nct ectodomain contains several glycosylation
sites.
2006). The two aspartate residues forming the active site of γ-secretase are located
within the TMD6 and TMD7 of PS1/2 and mutation of either of these residues
abolished γ-secretase activity (Wolfe et al., 1999). The D385 residue within TMD7
is part of a highly conserved GXGD motif, thus giving rise to the name GXGD-
type aspartyl proteases for the family of such proteases. After the assembly of all
subunits the PS1/2 holoprotein is cleaved into an N-terminal (PS-NTF, ∼30 kDa)
and C-terminal (PS-CTF, ∼20 kDa) fragment most likely in an autoproteolytic way
(Thinakaran et al., 1996; Edbauer et al., 2003). The cleavage site is located in an
intracellular loop between the TMD6 and TMD7 that possibly folds back into the
membrane to be cleaved by the holoprotein. As of today, there are 177 and 14
FAD-linked mutations described for PS1 and PS2, respectively (Alzheimer Disease
& Frontotemporal Dementia Mutation Database, 2009). The FAD-linked mutations
in PS1/2 lead to an altered specificity of the γ-secretase cleavage within βAPP-CTF.
Thus, the ratio of generated Aβ42 versus Aβ40 is increased as it was described for
FAD-linked mutations in APP before (see 1.2.1).
The presence of PS in a high-molecular-weight complex already suggested that
other subunits are involved in the γ-secretase activity (Li et al., 2000). Accordingly,
Nct was identified as a second subunit (Yu et al., 2000; Edbauer et al., 2002). In
its mature form it is a highly glycosylated type I transmembrane protein of ∼120
kDa. Nct binds to the new N-terminus of shedded substrates via its ectodomain,
thereby acting as a substrate receptor for γ-secretase (Shah et al., 2005). Aph-1
and Pen2 were identified in a genetic screen in C. elegans (Francis et al., 2002).
Both proteins are highly hydrophobic with 7 and 2 TMDs, respectively (figure 1.4).
Aph-1 has 2 human homologs (Aph-1a and Aph-1b) of which Aph-1a has a short
and long splice form (Aph-1aS and Aph-1aL). The three Aph-1 isoforms and the two
presenilins permit up to 6 different γ-secretase complexes (Shirotani et al., 2004b)
that differ in specificity (Serneels et al., 2005; Lai et al., 2003; Mastrangelo et al.,
6
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2005). Pen2 has a pivotal role in the stabilisation of the PS fragments (Prokop et al.,
2004; Hasegawa et al., 2004) and there is first evidence that FAD-linked mutations
exist therein (Frigerio et al., 2005). In contrast, no function was assigned to Aph-1
so far.
The cleavage of APP by γ-secretase is a stepwise process (figure 1.3) and the
different cleavage sites were denominated with greek letters. The first cleavage at
the -site releases AICD to the cytosol. Subsequently, the remaining stub is cleaved
at ζ-site and several γ-sites until the respective Aβ or p3 peptide is short enough to
be released from the membrane into the extracellular space. It was demonstrated
that already the -cleavage determines the subsequent cleavages since γ-secretase
cleaves the remaining stub at every third amino acid. Thus, two sequences of Aβ
cleavages can occur depending on the position of the first -cleavage: Aβ49() -
Aβ46(ζ) - Aβ43(γ) - Aβ40(γ) - Aβ37(γ) or Aβ48() - Aβ45(ζ) - Aβ42(γ) - Aβ39(γ)
(Qi-Takahara et al., 2005, reviewed in Steiner et al., 2008a)(figure 1.3). However,
the situation observed in vivo is much more complicated since N- and C-terminal
truncations lead to a broad range of detectable Aβ peptides (Haass et al., 1992; Wang
et al., 1996). The variability of detectable Aβ peptides ranges from the prominent
Aβ1−40 and Aβ1−42 over Aβ3−40 and Aβ1−38 to rare species like Aβ11−34.
1.2.3 The amyloid cascade hypothesis
All FAD-linked mutations lead to an increased ratio of generated Aβ42 versus
Aβ40 or to an overall increase in Aβ production. Additionally, reduced clearance of
Aβ peptides could contribute to elevated Aβ levels in the brain. These changes in
Aβ metabolism are supposed to be the first step in the cascade of pathogenic events
leading to AD (Selkoe, 2001, revised in Haass and Selkoe, 2007)(figure 1.5).
1.3 The secretory pathway
1.3.1 Overview
By revealing the importance of organelles like the endoplasmic reticulum (ER)
and the Golgi apparatus for protein secretion in the 1960s, Pallade and others laid
the ground for our current understanding of intracellular transport. Using ultra-
structural analysis and pulse chase experiments they disclosed the role of different
organelles in exocrine cells of the pancreas and they separated protein secretion from
other processes like translation (Jamieson and Palade, 1967a,b, 1968a,b). The secre-
tory pathway consists of the following organelles: ER, ER-Golgi intermediate com-
partment (ERGIC), cis-Golgi network (CGN), Golgi apparatus and the trans-Golgi
network (TGN). These organelles differ in structure, function, lipid composition and
enzymatic instrumentation, but they are interconnected by dynamic membrane traf-
fic (Harter and Wieland, 1996; Dalbey and Heijne, 2002). The tasks of the secretory
pathway include membrane insertion, folding and complex assembly, modification,
transport and (regulated) secretion of proteins. All in all, the secretory pathway
is the cellular factory for the majority of membrane bound and secreted proteins
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Figure 1.5: The amyloid cascade hypothesis (Selkoe, 2001; Haass and Selkoe, 2007).
(summarised in figure 1.6).
Proteins enter the secretory pathway by co-translational translocation into the
ER, where they are properly folded and glycoproteins obtain initial glycosylations.
In parallel, the TMDs of membrane proteins are inserted into the ER membrane
(Dalbey and Heijne, 2002). Once proteins are in a proper conformation, they are
sorted into budding vesicles that are coated with COPII coatomer proteins. COPII
vesicles then move anterogradely to the ERGIC which comprises an additional sort-
ing station between the ER and the cis-Golgi. Larger ERGIC compartments that
are generated by the fusion of COPII vesicles (Klumperman, 2000) most likely de-
velope into early Golgi cisternae. Movement through the Golgi apparatus results
from cisternal maturation and does according to current models not involve bud-
ding of anterograde vesicles (Pelham, 2001). An entire Golgi cisternae physically
moves from the CGN to the TGN while its enzymatic instrumentation is modified
by retrogradely moving vesicles from later Golgi stages. In the course of Golgi tran-
sit glycoproteins are heavily modified by the stepwise exposure to different glycosyl
transferases (Helenius and Aebi, 2001). The TGN is the major branch point of the
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Figure 1.6: Overview over the secretory pathway and ER retention signals. A) Protein
secretion through the secretory pathway requires a complex machinery. 1
Proteins that are determined for the secretory pathway are co-translationally
transported into the ER. 2 Anterograde transport via COPII vesicles from
the ER to the ERGIC or CGN. 3 and 5 Retrograde transport via COPI
vesicles to the ER and between different compartments of the Golgi appa-
ratus, respectively. 4 Anterograde transport within the Golgi apparatus via
cisternal maturation. 6 Regulated protein secretion via densely packed se-
cretory granules. 7 Continuous secretion via exocytosis. 8 Transport to
the lysosomal/endosomal compartment. Figure modified after Lodish, 2007.
B) Different ER retention signals were identified. TMD-based signals might
be divided into two groups since signals with charged residues (dark blue)
seem to work differently than non-charged signals (red). In membrane pro-
teins KKXX (pink) and RXR (yellow) signals have been described. For
lumenal proteins the KDEL signal (light blue) is known. Additionally, for
all glycoproteins (membrane bound or soluble) the glycans (green) may fa-
cilitate ER retention.
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secretory pathway, where proteins are sorted to at least three different vesicle types.
Type one is dedicated to exocytosis, releasing proteins to the plasma membrane or
the cell exterior in a continuous process. The second type is also targeted to the
plasma membrane, although these vesicles undergo exocytosis only after a distinct
stimulus. These vesicles are called secretory granules or secretory vesicles and are
mainly found in highly specialised secretory active cells. The last type transports
proteins to the lysosomes. The entire process is guided by signal sequences that
cause either retention in or exit from a distinct compartment (Ikonen and Simons,
1998).
1.3.2 ER retention signals
Different reasons necessitate that proteins stay in the ER. On the one hand,
misfolding and improper assembly of secreted proteins have to be recognised by
the ER quality control and the affected proteins have to be retained in the ER (see
section 1.3.3). On the other hand, resident ER proteins (e.g. chaperones) exert their
function in the ER and therefore they have to be kept in place. ER localisation of
proteins is achieved in different ways. Exclusion from anterogradely moving COPII
vesicles is supposed to be the primary mechanism localising proteins to the ER
(Barlowe, 2000; Dalbey and Heijne, 2002). Moreover, specific signal sequences were
identified that mediate ER retention or promote retrograde transport via COPI
vesicles once a protein is mislocalised to the ERGIC or cis-Golgi. These signals can
be cytoplasmic, lumenal or within TMDs (figure 1.6B).
The best characterised signal is the KDEL sequence (HDEL in yeast) found
at the very C-terminus of ER resident chaperones like BiP and it is bound by
the KDEL receptor (Erd2p in yeast) in the cis-Golgi. The complex of the KDEL
receptor and the substrate protein is subsequently packaged into COPI vesicles and
transported to the ER (Aoe et al., 1998). The KDEL receptor itself has a dilysine
motif (KKXX, with X = any amino acid) at the end of the cytoplasmic C-terminus,
which is found in several ER localised transmembrane proteins (Pelham, 1995). The
KKXX motive directly interacts with COPI coatomers, thus promoting the sorting
into COPI vesicles and the retrograde transport to the ER (Cosson and Letourneur,
1997).
Zerangue et al., 1999 identified a novel type of ER retention signals in the cyto-
plasmic domains of Kir6.2 and SUR1, both subunits of ATP-sensitive K+ channels
(KATP ). These signals are based on two arginines (RXR). Meanwhile, signals of the
RXR type were identified for example in the γ-aminobutyric acid (GABA) receptor
subunit GABAB-R1 (Margeta-Mitrovic et al., 2000), the human-specific p33 isoform
of the MHC class II-associated invariant chain Ii (Iip33)(Schutze et al., 1994) and
the N-methyl-D-aspartic acid (NMDA) receptor splice variants NR1-1 and NR1-3
(Standley et al., 2000). Similarly to KKXX signals, ER retention triggered by RXR
type signals is mediated by the binding of COPI coatomers to the arginines (O’Kelly
et al., 2002; Yuan et al., 2003; Michelsen et al., 2007).
The knowledge about TMD-based ER retention signals is less clear. In their
ground breaking work in the early 1990s the Klausner group characterised a degra-
dation and ER retention signal in the TMD of TCRα. This signal depends on
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two positively charged residues within the TMD, that most likely destabilise the
entire TMD (Bonifacino et al., 1990a,b). Hence, it appears that the identified sig-
nal primarily targets the carrying protein to ER-associated degradation (ERAD)
and in this way causes ER localisation. This view is supported by the findings of
Letourneur et al., 1995 for the TMD of human high affinity receptor for immunoglob-
ulin E (FcRI) that contains a negatively charged amino acid.
On the other hand, TMD-based ER retention signals were described that depend
on polar amino acids. Such signals were identified for example in the nicotinic
acetylcholine receptor (AChR)(Wang et al., 2002), Nct (Spasic et al., 2007) and
Pen2 (this study). In yeast Rer1p was implicated in the retention of TMD-based
retention signals that are based on polar residues (Sato et al., 1995, 1996, 1997, 2003,
2004)(see section 1.4). This finding was confirmed in mammals for Pen2 (this study)
and Nct (Spasic et al., 2007). All in all, no agreement exists which determinants
lead to TMD-based ER retention and how this retention is accomplished.
Interestingly, there exist also ER export signals like the diacidic DXD motif in
CFTR (cystic fibrosis transmembrane conductance regulator). In contrast to ER
retention signals, these signals mediate the binding to COPII coatomers and thus
promote anterograde transport via COPII vesicles (Wang et al., 2004).
1.3.3 Quality control in the ER
All proteins that traffic through the secretory pathway are subjected to a quality
control in the ER. Since later Golgi compartments do not generally support protein
folding or exert quality control, it is of highest importance to keep misfolded or
unassembled proteins in the ER (Mezzacasa and Helenius, 2002). Folding and qual-
ity control in the ER include formation of disulfide bonds, addition and modification
of glycans, proteolytic cleavages, minimisation of free energy and assembly of mul-
timeric complexes. An entire set of ER-resident chaperones and folding sensors is
facilitating and controlling these processes. Among these proteins are BiP, calnexin,
calreticulin, glucose-regulated protein 94 (GRP94) and members of the families of
peptidyl-prolyl isomerases (PPI) and protein disulfide isomerases (PDI)(Ellgaard
and Helenius, 2003).
The best understood mechanism of quality control in the ER is the calnexin/cal-
reticulin cycle. This cycle applies for glycoproteins that have their folding status
marked by specific modifications of their glycan trees. To this end, the preformed
glycan trees that were added to asparagines by oligosaccharyltransferase are trimmed
by two glucose units by glucosidases I and II. The monoglucosylated glycoprotein
is then bound by calreticulin (ER lumen) or calnexin (ER membrane) which are
themselves associated with further chaperones. Cleavage of the last glucose re-
leases the glycoprotein from calnexin/calreticulin and the folding status is probed
by UDP-glucose:glycoprotein glucosyltransferase (GT). If misfolding is detected,
GT adds a terminal glucose to the glycoprotein and thereby promotes reassocia-
tion with calnexin/calreticulin. If this cycle of association to and dissociation from
calnexin/calreticulin exceeds a distinct time span, the glycoprotein is targeted for
ERAD by the removal of a mannose in another branch of the glycan tree. Gly-
coproteins marked in this way are bound by the lectin EDEM (ER degradation-
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enhancing α-mannosidase-like protein) that most likely promotes retrotranslocation
to the cytoplasm. There the misfolded protein is ubiquitinylated and degraded via
the proteasome (Yoshida et al., 2002; Ellgaard and Helenius, 2003; Helenius and
Aebi, 2004).
Different mechanisms are involved in probing the assembly status of multimeric
complexes like ion channels or cell surface receptors. These mechanisms are based
on ER retention signals (see section 1.3.2) that are masked after correct assembly
of the multimeric complex (for reviews see Nufer and Hauri, 2003; Michelsen et al.,
2005). In case of the GABAB receptor the masking of an ER retention signal
was characterised down to the structural level. The GABAB-R1 subunit carries a
RSRR (RXR type) ER retention motif in the cytoplasmic C-terminus. This motif
immediately follows a region that mediates the binding to the GABAB-R2 subunit
by forming a coiled-coil between the C-termini of the two subunits. The structural
rearrangement in this area causes the masking of the ER retention signal after the
coiled-coil has formed (Margeta-Mitrovic et al., 2000)(figure 1.7A).
Other examples describe the involvement of 14-3-3 proteins. KATP channels
contain RXR type retention signals in their α (Kir6.1/2) and β (SUR1) subunits. At
least for the ER retention signal in Kir6.2 it was demonstrated that oligomerization
of this signal sequence recruits 14-3-3 proteins in vitro and in vivo. The recruited
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Figure 1.7: Masking of cytoplasmic ER retention signals is achieved in different ways.
Orange rectangles indicate cytoplasmic ER retention signals. A) Steric
masking: coiled-coil formation between the C-termini of the two GABAB
receptor subunits R1 and R2 cause the masking of an adjacent ER reten-
tion signal in the R1 subunit (Margeta-Mitrovic et al., 2000). B) Masking
by 14-3-3 proteins: Iip35 (Ii) is phosphorylated at a residue in the vicinity
of the Arg-based signal. Subsequent recruitment of 14-3-3 protein (purple
hexagons) causes masking of the signal (Kuwana et al., 1998). Addition-
ally, steric masking has also been implicated for the MHC class II complex
(Khalil et al., 2003). C) Masking by PDZ-domain protein: NMDA receptor
splice form NR1-3 has the C1 and C2’ cassette present in its C-terminus.
The C1 contains a cytosolic ER retention signal that is masked by bind-
ing of a PDZ-domain protein (green pentagon) to the adjacent C2’ cassette
(Standley et al., 2000). Modified after Michelsen et al., 2005.
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14-3-3 proteins compete with the COPI vesicle coat and thus with ER retention
(Zerangue et al., 1999; Yuan et al., 2003). 14-3-3 protein have also been implicated
in the ER exit of Iip35 that also contains a RXR type signal. In this case the
phosphorylation of the serine residue next to the retention signal results in the
binding of 14-3-3 proteins and the masking of the ER retention motif. However,
the impact of this masking on the assembly of the entire Ii-MHC-complex is not
completely clarified (Kuwana et al., 1998; Khalil et al., 2003, 2005)(figure 1.7B).
A very similar mechanism was described for KCNK3 (K+ channel, subfamily K,
member 3)(O’Kelly et al., 2002).
Furthermore, Standley et al., 2000 described a RXR type ER retention motif in
the C1 cassette of the NMDA receptor splice variants NR1-1 and NR1-3. The NR1-3
splice variant contains a PDZ binding site within the C2’ cassette and binding of
PSD-95 family members causes masking of the retention signal in the C1 cassette
(figure 1.7C). Moreover, Scott et al., 2001 described that the very same signal can be
inactivated by PKC-mediated phosphorylation in the NMDA receptor splice form
NR1-1 that also contains the C1 but lacks the C2’ cassette. The masking of dilysine
ER retention signals by nonspecific sterical hindrance was shown for the cytoplasmic
C-terminus of FcRI(Letourneur et al., 1995).
Less knowledge exists on the masking of TMD-based ER retention signals. Boni-
facino et al., 1990a demonstrated that the positively charged residues of the ER re-
tention signal in the TMD of TCRα interacts with the negatively charged residues
in the TMD of another subunit of the TCR complex, namely CD3-δ. Most notably,
this interaction causes stabilisation of a Tac reporter protein carrying the TCRα-
TMD, since the processes of TMD-mediated ER retention and protein degradation
are intimately coupled in their study (Bonifacino et al., 1990a,b). More recently,
a study by Horak et al., 2008 revealed an ER retention signal in TMD3 of NMDA
receptor subunits NR1 and NR2B. In the functional, tetrameric receptor (NR1-NR1-
NR2B-NR2B stoichiometry) these signals are masked by an interaction of NR1TMD3
and NR2BTMD3 with the TMD4 of NR1.
Taken together, the literature shows a diversity of mechanisms causing masking
of cytoplasmic ER retention signals. In contrast, the picture of TMD-based retention
signals seems to be split. On the one hand, detailed knowledge exists on signals that
are based on charged residues (like TCRα). Masking of these ER retention signals is
accompanied by stabilisation of the harbouring protein, which makes both processes
hard to dissect. On the other hand, only little knowledge exists on the masking of
other TMD-based retention signals.
1.4 The sorting receptor Rer1
The RER1 gene (Return to the ER OR Retention in the ER) was found mutated
in a yeast strain that failed to localise Sec12p to the early compartments of the
secretory pathway (cis-Golgi and ER)(Nishikawa and Nakano, 1993; Boehm et al.,
1994). RER1 encodes a hydrophobic protein of 188 amino acids with a molecular
mass of 22 kDa and four TMDs (Boehm et al., 1994; Sato et al., 1995)(figure 1.8).
Rer1p cycles between the ER and the Golgi apparatus via COPI and COPII vesicles,
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Figure 1.8: Rer1 has a W-topology. N- and C-terminus face the cytosol and only 6
residues are exposed to the ER lumen (Boehm et al., 1994; Sato et al.,
1995).
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Figure 1.9: Rer1 is a retrieval receptor for mislocalised ER proteins. Rer1 recognises
a signal in a TMD of an escaped (mislocalised) ER protein (substrate of
Rer1). After binding to its substrate the Rer1-substrate complex is sorted
into COPI vesicles and transported to the ER where the substrate is re-
leased. Subsequently, Rer1 cycles back to the cis-Golgi via COPII vesicles
(not shown here). Alternatively, Rer1 could act as a sorting factor leading
its substrate to COPI vesicles without entering the vesicles itself.
although the steady state shows localisation to the cis-Golgi (Boehm et al., 1997;
Sato et al., 1995, 2001). Rer1p binds to COPI subunits via a dilysine-like motif in
its C-terminus perfectly matching to its dynamical localisation (Sato et al., 2001).
Robust evidence exists that Rer1p mediates the localisation of target proteins
to the ER via an interaction with the TMDs of target proteins. Although no clear
consensus sequence for Rer1p binding was identified, the presence of polar residues
in the hydrophobic context of a TMD is a common feature of all Rer1p substrates.
The identified substrates of Rer1p exhibit different types of membrane topology
and can also be subunits of multimeric complexes (Sato et al., 1996, 1997, 2001,
2003, 2004). The steady-state localisation and the cycling between the ER and
14
Introduction
the Golgi suggests that it functions very similar to the well studied KDEL receptor
(HDEL in yeast)(Pelham, 1996)(figure 1.9). Thus, the localisation of proteins to the
ER by Rer1p is more by retrieval than by retention, although both terms are used
synonymously in this study. On the other hand, it is also possible that Rer1p acts as
a sorting factor in the Golgi. In this case Rer1p would not enter COPI vesicles in a
complex with its substrate. However, both proposed models are hard to distinguish
(Boehm et al., 1997).
Rer1p is highly conserved from yeast to human and the human homolog Rer1
complements Rer1p deficient yeast strains (Fullekrug et al., 1997). Human Rer1
has 196 amino acids and shares 64 % similarity (44 % identity) with Rer1p. Unlike
yeast Rer1p, the mammalian homolog Rer1 shows co-localisation with ERGIC-53,
indicating its presence in the ERGIC besides its localisation in the Golgi. In mam-
malians only the γ-secretase subunits Nct (Spasic et al., 2007) and Pen2 (this study)
were described to be Rer1 substrates. Nevertheless, a search for proteins carrying
polar residues in their TMDs in the TMbase database (ftp://ftp.ncbi.nih.gov/
repository/TMbase/) revealed a bulk of potential Rer1 substrates in mammals
(Christoph Kaether, unpublished data).
1.5 Assembly of the γ-secretase
The spatial and temporal aspects of γ-secretase assembly were intensively studied
in the recent years. The major findings are: (1) Stable knock down of Nct causes
reduced levels of PS (Edbauer et al., 2002), Aph-1 (Capell et al., 2003) and Pen2
(Steiner et al., 2002). Furthermore, Nct forms a stable interaction with Aph-1 also
in the absence of PS and Pen2 (Shirotani et al., 2004a). (2) Aph-1 overexpression
stabilises the PS holoprotein (Takasugi et al., 2003) and Aph-1 directly interacts
with PS and Nct (Lee et al., 2002; Gu et al., 2003). (3) PS1−/−/PS2−/− double
knock out MEFs (PSDKO cells) show dramatically reduced levels of Pen2 while the
levels of Nct and Aph-1 are only slightly reduced (Steiner et al., 2002; Gu et al.,
2003). In PSDKO cells Nct is only present in its immature form due to retention in
the ER (Edbauer et al., 2002). (4) Stable knock down of Pen2 results in attenuation
of PS endoproteolysis and Nct maturation (Prokop et al., 2004) and Pen2 directly
binds to PS (Watanabe et al., 2005; Kim and Sisodia, 2005a). Additionally, triple
knock down of Nct, Aph-1 and Pen2 decreases the levels of PS holoprotein to a
similar extent as knock down of Nct and Aph-1 alone. This places the function of
Pen2 downstream of those of Nct and Aph-1 (Takasugi et al., 2003). (5) Immediately
after complex assembly the Nct ectodomain undergoes a conformational change and
PS is endoproteolysed (Shirotani et al., 2003; Capell et al., 2005). (6) Chemical
crosslinking of γ-secretase subunits reveals close neighbourhood between Pen2 and
PS1-NTF, Aph-1 and PS1-CTF, Aph-1 and Nct and of course PS1-NTF and PS1-
CTF (Steiner et al., 2008b). (7) γ-secretase is assembled in the ER (Kim et al.,
2004; Capell et al., 2005) and the assembled complex exerts its function at the
plasma membrane or in the endosomal/lysosomal system (Kaether et al., 2006).
These findings led to a model suggesting a stepwise assembly of γ-secretase.
First, Aph-1 and Nct form an initial scaffold in the ER membrane. Subsequently,
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Figure 1.10: γ-secretase assembles in a stepwise manner. Nct and Aph-1 form an ER-
localised scaffold that recruits PS. Pen2 binds to the trimeric complex via
an interaction with the PS-TMD4. Unassembled complex subunits can be
degraded via ERAD. Once the quaternary complex has formed, PS un-
dergoes endoproteolytic cleavage, the Nct ectodomain folds into a com-
pact trypsin-resistent conformation and the complex is transported to the
plasma membrane.
PS binds to this scaffold and is thereby stabilised. Last, Pen2 is incorporated into
the complex resulting in endoproteolytic cleavage of PS and structural changes in
the Nct ectodomain (reviewed in Dries and Yu, 2008)(see figure 1.10).
Kaether et al., 2004 proposed a hypothetical model for the quality control of
γ-secretase assembly that adopts ER quality control mechanisms known from ion
channels and cell surface receptors. In this model ER retention signals on each
γ-secretase subunit assure ER localisation of the isolated subunits and assembly
intermediates. The non-assembled subunits might be degraded by ERAD as it was
shown for Pen2 (Bergman et al., 2004a). Supporting this model, ER retention signals
were identified in the PS1 C-terminus (PS1-TMD9)(Kaether et al., 2004), Nct-TMD
(Spasic et al., 2007) and Pen2-TMD1 and PS1-TMD4 (this study). The proposed
model implies that upon complex assembly all ER retention signals are inactivated
and the ER export is permitted.
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1.6 Aims of this work
This work focused on quality control mechanisms acting in the course of the
assembly of the γ-secretase complex. In particular, additional evidence should be
provided supporting the hypothesis suggested by Kaether et al., 2004, who pro-
posed ER retention signals as a checkpoint in the ER quality control of γ-secretase.
Specifically, the following aims were addressed:
(a) Identification of novel ER retention signals a
In a first step novel ER retention signals should be identified on different γ-
secretase subunits. The identified signals should be intensively characterised
and their relevance for the full-length protein had to be tested. This work
concentrated on signals within the TMDs of γ-secretase.
(b) Identification of the machinery involved in TMD-based retention a
Since only little knowledge existed on the mechanisms contributing to TMD-
based ER retention, these mechanisms should be intensively studied. A po-
tential candidate protein involved in ER retention in yeast was Rer1.
(c) Analysis of processes leading to the masking of ER retention signals
ER retention signals that are involved in the ER quality control of complex
assembly need to be inactivated after correct assembly to allow ER export
of the complex. Thus, mechanisms resulting in the masking of ER retention
signals in γ-secretase should be identified.
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Material and methods
2.1 Cell culture
2.1.1 Cell lines
The eucaryotic cell lines used to express proteins are listed in table 2.1.
Table 2.1: Cell lines used
cell line specifications reference/source
HEK-293
Ad5 transformed human embryonic
kidney cells
ATCC-number CRL-1573
HeLa Kyoto strongly adherent HeLa isolate
gift by R. Pepperkok
(EMBL, Heidelberg)
Swe
HEK-293 cells, stably expressing APP
with the Swedish double mutation
Citron et al., 1992
CHO Chinese hamster ovary cell line
gift by B. Schwappach
(Manchester, UK)
2.1.2 Culture conditions
All cells were cultured under standard conditions (37 , 5 % CO2, 90 % hu-
midity). Cell culture work was performed under sterile conditions using a sterile
laminar flow box. Cell lines were cultured in DMEM medium (Gibco, #61965)
supplemented with 1 % Penicillin/Streptomycin (PAA, #P11-010) and 10 % FCS
(Invitrogen, #10270). Every 3-4 days cells were detached from cell culture dish
(BD Falcon) with 0.05 % Trypsin/EDTA-solution (Invitrogen, #25300) and split in
appropriate ratios.
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2.1.3 Transfection
To transfect cells with Plasmid-DNA Lipofectamine 2000 (Invitrogen, #11668)
and Turbofect (Fermentas, #R0531) were used. Transfections were carried out
strictly according to the manufacturers protocol, yet the amount of used DNA was
varied within the range supposed by the manufacturer. Lipofectamine 2000 was
used according to the manufacturers protocol for transfecting cells with siRNA, but
the amount of used siRNA was increased to 250 pmol per well on a 6-well plate. For
bigger or smaller culture vessels, transfections were scaled up or down appropriately.
To generate stable cell lines cells were split to 1:20, 1:50, 1:100 and 1:250 the day
after the transfection. 12 hours later the respective antibiotic (see table 2.2) was
added and selection was performed over approximately 3 weeks. Subsequently, either
clones were picked and expanded or a cell pool was generated.
Table 2.2: Antibiotics used for selection of stable cell lines
antibiotic final concentration supplier
Zeocin 200 µg/ml Invitrogen, #R250
Geneticin
®
250 µg/ml PAA, #P27-011
Hygromycin B 100 µg/ml PAA, #P02-011
2.2 Plasmids
To express proteins in eucaryotic cells several DNA plasmid vectors were con-
structed. The used constructs are listed in table 2.4. Detailed maps and construc-
tion descriptions can be found in the appendix (A.1) for the constructs that were
described here for the first time. Details for the used vectors are listed in table 2.3.
Table 2.3: Vectors used for eucaryotic protein expression
name resistances supplier
pcDNA3.1/Hygro(+) Hygromycin B, Ampicillin Invitrogen, #V87020
pcDNA3.1/Zeo(+) Zeocin, Ampicillin Invitrogen, #V86020
pcDNA4/myc-His Zeocin, Ampicillin Invitrogen, #V86320
pcDNA6/V5-His Blasticidin, Ampicillin Invitrogen #V22020
pCMV-myc Ampicillin Clontech #631604
pmaxGFP Kanamycin AMAXA
pSuper Ampicillin
Oligoengine
#VEC-PBS-0001
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Table 2.4: List of DNA constructs used for eukaryotic protein expression.
expressed construct vector reference/source
CD4 pcDNA3.1/Hygro(+) Christoph Kaether
CD4-Pen2TMD1 pcDNA3.1/Hygro(+)
Christoph Kaether
(Kaether et al., 2007)
CD4-RXR pcDNA3.1/Hygro(+)
Lily E. Jan
(Zerangue et al., 1999)
CD4-PS1TMD4 pcDNA3.1/Zeo(+) Appendix A.1
CD4-PS1TMD4mut pcDNA3.1/Zeo(+) Appendix A.1
CD4-Pen2TMD1-EGFP pcDNA3.1/Hygro(+) Appendix A.1
CD4-PS1TMD4-myc pcDNA4/myc-His
Michael Zocher
(Fassler et al., 2009)
CD4-RXR-myc pcDNA4/myc-His
Michael Zocher
(Fassler et al., 2009)
Tac pcDNA3.1/Zeo(+)
Christina Valkova
(Fassler et al., 2009)
Tac-PS1TMD4 pcDNA3.1/Zeo(+) Appendix A.1
Tac-RXR pcDNA3.1/Zeo(+) Appendix A.1
PE pcDNA3.1/Zeo(+)
Christoph Kaether
(Kaether et al., 2002)
PE−PALP pcDNA3.1/Zeo(+)
Christoph Kaether
(Kaether et al., 2004)
PE−WNF pcDNA3.1/Zeo(+) Appendix A.1
PE−PALP−WNF pcDNA3.1/Zeo(+) Appendix A.1
PE ∆7 pcDNA3.1/Zeo(+)
Christoph Kaether
(Kaether et al., 2004)
PE ∆7−PALP pcDNA3.1/Zeo(+)
Christoph Kaether
(Kaether et al., 2004)
PE ∆7−WNF pcDNA3.1/Zeo(+) Appendix A.1
PE ∆7−PALP−WNF pcDNA3.1/Zeo(+) Appendix A.1
Rer1-V5 pcDNA6/V5-His
Christoph Kaether
(Kaether et al., 2007)
mycPen2 pCMV-myc
Christoph Kaether
(Kaether et al., 2007)
Pen2-shRNA pSuper (Prokop et al., 2004)
Notch∆E-EGFP pcDNA3.1/Hygro(+)
Kerstin Hu¨nniger,
Raphael Kopan
(Schroeter et al., 1998)
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Briefly, the needed DNA fragments were amplified by PCR with appropriate
primers using standard protocols. PCR fragments were purified from agarose gel
using the NucleoSpin
®
Extract II kit (Macherey-Nagel, #740609) and were cloned
into pCR
®
2.1-TOPO
®
using TOPO-TA cloning
®
kit (Invitrogen, #K4500). Clones
with inserted PCR fragment were identified by the absence of β-Galactosidase activ-
ity and plasmids were isolated using the NucleoSpin
®
Plasmid kit (Macherey-Nagel,
#740588). DNA fragments were excised from pCR
®
2.1-TOPO
®
using respective en-
zymes, purified by agarose gel electrophoresis and ligated into the required destina-
tion vector.
2.3 Protein biochemical methods
2.3.1 Preparation of cell pellets
The desired cells were placed on ice and the culture medium was aspirated.
Afterwards, cells were washed once with ice cold PBS, 1 ml cold PBS was added and
cells were scraped off. The cell suspension was transferred to a microcentrifuge tube
and centrifuged for 10 minutes at 2,000 g at 4 . The supernatant was discarded
and the cell pellet was frozen at -80 .
2.3.2 Cell lysis
Cell pellets were dissolved in an appropriate volume of STEN lysis buffer (50 mM
Tris-HCl pH 7.6, 150 mM NaCl, 2 mM EDTA, 1 % NP-40) or CHAPSO lysis buffer
(150 mM Citrate buffer pH 6.4, 2 % CHAPSO), supplemented with 1:500 protease
inhibitor cocktail (SIGMA, #P8340). Samples were incubated for 30 min on ice
and during that time vortexed regularly. Subsequently, samples were centrifuged 15
minutes at 16,000 g and 4  and the supernatant (lysate) was transferred to a fresh
tube.
2.3.3 Immunoprecipitation
Protein concentration of STEN lysates was measured using the BCA assay kit
(Pierce, # 23225) and an equal protein mass was used in every IP sample. Samples
were titrated to equal volumes and preincubated with 30 µl slurry of Protein A
Sepharose (PAS) (Sigma, #P3391) or Protein G Sepharose (PGS) (GE Healthcare,
#17-0618-01) for 1 hour at 4  on a rotor rod. For rabbit and mouse IgG, PAS and
PGS was used, respectively. Preincubated lysates were recovered by centrifugation
for 3 minutes at 10,000 g and 0.5 µg of the IP antibody (see 2.5 for used antibodies)
was added to each sample. Lysates were incubated for 1 hour at 4  and afterwards
another 30 µl of PAS or PGS were added and the IP was incubated over night.
The next day, samples were washed once with 500 µl of STEN-NaCl (STEN +
175 mM NaCl), STEN-SDS (STEN + 0.1 % SDS) and STEN (50 mM Tris-HCl
pH 7.6, 150 mM NaCl, 2 mM EDTA, 0.2 % NP-40), respectively. To elute the
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immunoprecipitated protein, beads were heated to 65  for 10 min with 20 µl
2ÖLaemmli sample buffer.
Table 2.5: Antibodies used in (co-)immunoprecipitations.
antibody origin
mouse monoclonal anti-hCD4 DIATEC (EDU-2)
rabbit polyclonal anti-GFP Invitrogen (A11122)
mouse monoclonal anti-myc Santa Cruz (9E10)
mouse monoclonal anti-V5 Invitrogen (R960-25)
2.3.4 Co-immunoprecipitation
The protocol is identical to normal immunoprecipitations, but CHAPSO lysates
were used and different wash steps were applied. Beads were washed twice with
0.5 % CHAPSO in 150 mM Citrate buffer pH 6.4 and once with 150 mM Citrate
buffer pH 6.4. The used antibodies are listed in table 2.5
2.3.5 Deglycosylation assay
To assess the subcellular localisation of different CD4 reporter species, the resis-
tance to Endoglycosidase H (EndoH) was utilised. Immunoprecipitated CD4 protein
was eluted from PGS with 35 µl of deglycosylation elution buffer (100 mM Tris-HCl
pH 7.6, 10 mM DTT, 1 % SDS) by boiling 5 minutes at 95 . Of each IP sample
3Ö10 µl were recovered from the beads and divided into 3 tubes. These 3 sam-
ples were subject to 3 different treatments (nt, H, N). The nt (non-treated) sample
was directly boiled with 2.5 µl of 5ÖLaemmli sample buffer and stored at 4 
over night. The samples H and F were subjected to deglycosylation with EndoH
or N-glycosidase F, respectively, as it is described in table 2.6. Treatment with N-
glycosidase F leads to a complete removal of N-glycosylations, whereas treatment
with EndoH removes only glycosylations that have not been processed in later Golgi
compartments. Deglycosylation was performed over night at 37  and the samples
were TCA-precipitated the next day. The protein pellets were dissolved in 12.5 µl
1ÖLaemmli sample buffer (50 mM Tris-HCl pH 6.8, 2 % SDS, 6 % glycerol, 2.5 %
β-mercaptoethanol) and boiled 5 minutes at 95 . Connected PAGE samples were
loaded in the order ntHF onto a 10 % SDS-PAGE gel and a Western blot against
CD4 was performed as described in 2.3.6.
2.3.6 Western blot
After cell lysis (see 2.3.2) and measurement of protein concentration (see 2.3.3)
equal amounts of protein were boiled with 5Ö Laemmli sample buffer. For blots
against γ-secretase subunits and Rer1, samples were heated to 65  for 10 minutes
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Table 2.6: Reaction mix for EndoH and NGF treatments. EndoH and G5 reaction buffer
were from NEB (#P0702L). NGF buffer is 100 mM phosphate buffer pH 8.0,
25 mM EDTA, 0.1 % Triton-X-100, 0.2 % SDS, 0.1 % β-Mercaptoethanol
and NGF was obtained from Roche (#11365185001).
H F
10 µl IP eluate 10 µl IP eluate
10 µl G5 reaction buffer 88 µl NGF buffer
79 µl ddH2O 2 µl NGF
1 µl EndoH
to avoid protein aggregation. For all other blots samples were heated to 95  for
5 minutes. SDS-PAGE was performed using standard protocols (Sambrook and
Russell, 2001) and acrylamide concentrations between 6 % and 14 %. In some
cases pre-cast NovexR 10-20 % Tricine gels (Invitrogen, #EC66252 Box) were used.
By tank blotting proteins were transferred onto a PVDF membrane (Immobilon-
P, Millipore). Subsequently, the membrane was blocked for 1 hour with I-Block
(Applied Biosystems, #T2015), cut at appropriate positions if needed and incubated
with primary antibody over night at 4 . Wash steps were performed according to
standard protocols (Sambrook and Russell, 2001) and the membrane was incubated
with secondary antibody for 1 hour at room temperature. The blot was developed
using freshly mixed ECL solution (4 ml solution A (100 mM Tris-HCl pH 8.6, 0.025
% (w/v) Luminol), 400 µl solution B (0.11 % (w/v) para-Coumaric acid in DMSO),
1.2 µl 35 % H2O2) and a FUJI Super RX X-ray film. To detect another protein on
the same membrane, the membrane was stripped for 30 minutes at 50  with Strip
buffer (62.5 mM Tris-HCl pH 6.8, 2 % (w/v) SDS, 100 mM β-Mercaptoethanol).
All used antibodies are listed in table 2.7.
2.4 Immunocytochemistry
Cells were seeded onto cover slips, which were coated with 0.05 mg/ml poly-L-
lysine in case HEK-293 cells were used for immunocytochemistry. Cells were fixed
with 4 % Paraformaldehyde for 20 minutes and quenched with 50 mM NH4Cl for 10
minutes. To permeabilise the cells, cover slips were incubated in 0.2 % Triton-X-100
for 2 minutes. Unspecific signals were blocked with blockmedium (2 % FCS, 2 %
BSA, 0.2 % fish gelatine in PBS pH 7.4) for 10 minutes. Primary and secondary
antibodies were diluted in blockmedium as described in table 2.8. and the cells were
incubated with the respective antibody solution for 20 minutes each. Nuclei were
stained with 1 µg/ml DAPI for 5 minutes. In the end, cover slips were mounted onto
a microscope slide with MOWIOL mounting medium and dried at room temperature
over night. All solutions were prepared in PBS pH 7.4 and all steps were performed
at room temperature. Incubations were performed in a humified, dark chamber.
Optionally, a surface antigen stain was performed prior to fixation. To this end,
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Table 2.7: Primary and secondary (HRP-coupled) antibodies used for Western blot.
antibody origin dilution
mouse monoclonal anti-myc Santa Cruz (9E10) 1:1,000
mouse monoclonal anti-GFP Clontech (JL-8) 1:1,000
rabbit polyclonal anti-βActin Abcam (ab8227) 1:10,000
rabbit polyclonal anti-hRer1 Kaether et al., 2007 (1120) 1:750
rabbit polyclonal anti-hCD4 Santa Cruz (H-370) 1:1,000
rabbit polyclonal anti-Nct SIGMA (N1660) 1:2,000
rabbit polyclonal anti-GFP Invitrogen (A11122) 1:1,000
rabbit polyclonal anti-cleaved Notch1 Cell Signaling (Val1744) 1:1,000
rabbit polyclonal anti-βAPP-CT Steiner et al., 2000 (6687) 1:300
rabbit polyclonal anti-Pen2 Steiner et al., 2002 (1638) 1:200
rabbit polyclonal anti-PS-NTF Walter et al., 1997 (2953) 1:500
goat polyclonal anti-rabbit
Promega (W4011) 1:5,000
IgG (H+L), HRP conjugate
goat polyclonal anti-mouse
Promega (W4021) 1:5,000
IgG (H+L), HRP conjugate
cover slips were initially incubated with the primary antibody diluted in cold PBS
+ 1 mM CaCl2 + 0.5 mM MgCl2 for 20 minutes on ice. Subsequently, cells were
fixed with 4 % Paraformaldehyde and processed further as described before.
2.4.1 Quantification of immunocytochemistry
To obtain quantitative results for the localisation of CD4-Pen2TMD1-EGFP the
CELLOMICS ArrayScan HCS Reader was used, providing a combination of auto-
mated microscopy and image analysis software. To this end, HeLa Kyoto CD4-
Pen2TMD1-EGFP cells were seeded into 96-well plates and transfected with siRNA
as described before. After 72 hours 96-well plates were placed on ice, and stained
for surface CD4 antigen with anti-mouse IgG Alexa Fluor
®
555 as secondary anti-
body. Additionally, cell nuclei were stained with DAPI. Images were acquired with
a 10Öobjective and analysed online by the software. Image acquisition was stopped
after the identification of 100 valid objects, which were characterised by a normal
nuclear shape (e.g. exclusion of mitotic cells) and a moderate expression of the
reporter protein. To obtain quantitative data a region of interest was generated by
expanding the nucleus by 7 pixels in all directions. Within the resulting ellipse the
average intensities of EGFP signal (representing total reporter protein) and Alexa
Fluor
®
555 signal (representing surface reporter protein) were measured and the ratio
was calculated as the ultimate score of the assay.
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Table 2.8: Primary and secondary (fluorophore-coupled) antibodies used for Immunocy-
tochemistry.
antibody origin dilution
mouse monoclonal anti-myc Santa Cruz (9E10) 1:500
mouse monoclonal anti-CD4 DIATEC (EDU-2) 1:500
mouse monoclonal anti-Calnexin Chemicon (MAB3126) 1:500
rabbit polyclonal anti-GFP Invitrogen (A11122) 1:500
rabbit polyclonal anti-Calnexin Abcam (ab13504) 1:200
rat monoclonal anti-mTac
Jo¨rg Stirnweiss (FSU Jena)
1:500
(PC61.73)
goat polyclonal anti-BiP Santa Cruz (aC-19) 1:80
Alexa Fluor
®
488 goat polyclonal, highly
Invitrogen (A-11034) 1:500
cross-adsorbed, anti-rabbit IgG (H+L)
Alexa Fluor
®
488 goat polyclonal, highly
Invitrogen (A-11029) 1:500
cross-adsorbed, anti-mouse IgG (H+L)
Alexa Fluor
®
555 goat polyclonal, highly
Invitrogen (A-21429) 1:500
cross-adsorbed, anti-rabbit IgG (H+L)
Alexa Fluor
®
555 goat polyclonal, highly
Invitrogen (A-21424) 1:500
cross-adsorbed, anti-mouse IgG (H+L)
Alexa Fluor
®
555 goat polyclonal
Invitrogen (A-21434) 1:500
anti-rat IgG (H+L)
Alexa Fluor
®
660 goat polyclonal
Invitrogen (A-21054) 1:500
anti-mouse IgG (H+L)
Alexa Fluor
®
488 donkey polyclonal
Invitrogen (A-21054) 1:500
anti-goat IgG (H+L)
2.5 FACS analysis
To quantify the surface localisation of CD4 reporter proteins FACS analysis
was utilised. To this end, cells were harvested using a sterile EDTA solution (2
mM EDTA, 1 % BSA in PBS) and 2 Ö200,000 cells were used per sample. Per
sample one set of cells was stained for surface antigens only, while the other set
was stained for surface and intracellular CD4 antigens. Cells were washed with
FACS buffer (2 % FBS in PBS) prior to the first staining step. Anti-hCD4-APC
(Allophycocyanin)(Miltenyi, #130-091-232) was diluted 1:10 in FACS buffer and
cells were stained with 25 µl antibody solution for 20 minutes on ice in the dark.
After washing twice with FACS buffer, cells were fixed and permeabilised using
the BD Cytofix/CytopermFixation/Permeabilization Solution Kit (BD Biosciences
Pharmingen, #554714). Thereafter, internal CD4 antigens were stained in the to-
tally stained sample set with 25 µl of 1:10 diluted anti-hCD4-APC for 20 minutes.
Finally, specimens were washed twice with FACS buffer. Additionally, intracellular
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myc antigens were stained for the FACS-based masking assay to allow gating on
double transfected cells. To this end, cells were stained with 25 µl 1:250 rabbit
polyclonal anti-myc (Santa Cruz, A-14) and 1:250 R-PE (R-Phycoerythrin) goat
polyclonal anti-rabbit IgG (H+L) (Invitrogen, P-2771MP) for 20 minutes each.
Specimen were measured on a BD FACSCaliburor BD FACSCantoII Flow Cy-
tometer and the obtained data were evaluated with the FlowJo software (version
5.4.3). The geometric mean of the APC fluorescence intensity of approximately
10,000 cells was used to calculate the percentage of surface CD4 antigen.
2.6 Statistical analysis
Statistical analysis was done using the R software package (R Development Core
Team, 2009). To test for a true difference of means, Welch Two Sample t-test was
applied via the function t.test() of R. A p-value < 0.05 was considered significant
and indicated with * and a p-value < 0.01 was considered highly significant and
indicated with **.
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Results
3.1 Pen2-TMD1 contains an ER retention signal
It has been described by Bergman et al., 2004a that γ-secretase subunit Pen2
is localised to the ER in PS1−/−/PS2−/−-MEF cells (PSDKO cells), which lack a
γ-secretase complex. Additionally, this finding was confirmed by our lab using N-
terminally EGFP-tagged Pen2 (Kaether et al., 2007). Thus, the unassembled Pen2
must be retained in the ER via intrinsic retention signals. Such signals could be
localised either in its cytoplasmic loop (Zerangue et al., 1999) or its TMDs, as it
was shown for a other proteins (Zerangue et al., 1999; Bonifacino et al., 1991).
To narrow down ER retention signals in Pen2, a series of CD4 reporter proteins
were constructed. Cluster of differentiation 4 (CD4) is a type I transmembrane
glycoprotein, with its N-terminus in the ER lumen and the C-terminus in the cytosol.
It is rapidly transported to the plasma membrane after synthesis and becomes N-
glycosylated at two positions of the lumenal part (Asn296, Asn325; figure 3.1A)
during the transport through the secretory pathway. It has been used previously as
a reporter protein to identify ER retention signals (Nilsson et al., 1989; Zerangue
et al., 2001; Kaether et al., 2004). Previous work in our lab by Johanna Scheuermann
suggested that Pen2-TMD1 conferred ER localisation to CD4 when being swapped
with the CD4-TMD. The first goal of the thesis presented was to verify and extend
these findings.
3.1.1 Pen2-TMD1 confers ER retention to a CD4 reporter
protein
The used CD4 reporter proteins CD4, CD4-Pen2TMD1 and CD4-RXR are de-
picted in figure 3.1A,B. In CD4-Pen2TMD1 the CD4-TMD was swapped with the
TMD1 of Pen2 plus three lumenal residues (REA), whereas CD4-RXR had the
last 36 amino acids of Kir6.2 fused to the cytoplasmic CD4 C-terminus. Thus, the
RXR ER retention signal within this 36 amino acids conferred ER retention to the
otherwise PM localised CD4 protein (Zerangue et al., 1999). CD4-Pen2TMD1 was
constructed by Johanna Scheuermann, whereas CD4 and CD4-RXR were a kind
gift by Lilly E. Jan (Howard Hughes Medical Institute, San Francisco, USA). The
CD4 reporter constructs were transiently transfected into Cos-7 cells and immuno-
cytochemistry with antibodies against CD4 and BiP revealed plasma membrane and
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Figure 3.1: CD4-Pen2TMD1 was retained in the ER in Cos-7 cells. A) Constructed
CD4 variants. B) Comparison of the TMD regions of the CD4 constructs.
In CD4-Pen2TMD1 the addition of the three following cytoplasmic amino
acids REA was necessary to achieve ER retention. C) Cos-7 cells were
transiently transfected with different CD4 variants. Cells were subjected
to immunofluorescence staining with antibodies against CD4 and the ER
marker BiP. Nuclei were stained with DAPI and cells were analysed by flu-
orescence microscopy. In the merge pictures CD4 was coloured red, BiP
green and DAPI blue. Scalebar 10 µm. The lower panel shows magnifica-
tions (magnif.) of the boxed areas above. Scalebar 2 µm. Arrowheads, PM
localisation; Arrows, ER localisation (nuclear envelope and reticular ER).
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Figure 3.2: CD4-Pen2TMD1 was retained in the ER in Swe cells. Swe cells stably ex-
pressing CD4 variants as indicated were subjected to immunofluorescence
staining with antibodies against CD4 and the ER marker Calreticulin. Nu-
clei were stained with DAPI. Pictures show optical sections obtained by flu-
orescence microscopy with an apotome slider module. In the merge picture
CD4 was coloured red, Calreticulin green and DAPI blue. Arrowheads, PM
localisation; Arrows, ER localisation (nuclear envelope and reticular ER);
Scalebar 10 µm.
ER localisation for the control constructs CD4 and CD4-RXR, respectively (figure
3.1C, first and second column). CD4-Pen2TMD1 was localised to the ER (figure
3.1C, third column), though a few cells showed additional weak plasma membrane
staining (data not shown). This indicated the presence of an ER retention signal
within the TMD1 of Pen2. Yet, the signal seemed to be weaker than the cytoplasmic
RXR signal, where all cells showed exclusively ER staining.
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To validate the results obtained in Cos-7 cells, Swe cell lines were generated
that stably expressed CD4, CD4-RXR and CD4-Pen2TMD1. The Swe cell line was
generated from a HEK-293 cells by stably overexpressing the amyloid precursor
protein with the Swedish double mutation (APPsw). The Swedish double mutation
(K595N, M596L) resulted in 6-8-fold increase of Aβ production compared to wild-
type APP and it was identified in a hereditary form of AD (Citron et al., 1992).
Thus, Swe cells provided the best prerequisites to measure γ-secretase activity in
cell-based assays. Since it was initially speculated that overexpression of the Pen2-
TMD1 might interfere with the γ-secretase assembly or activity, Swe cells were used
here to stably express CD4-Pen2TMD1.
The stable cell lines were prepared for immunofluorescence using anti-CD4 and
anti-Calreticulin antibodies. Microscopy was carried out on a Zeiss Axio Imager
with an ApoTome slider module, allowing confocal-like optical sections through the
Swe cells. The control constructs were localised as expected and CD4-Pen2TMD1
showed ER localisation (figure 3.2, column 3), confirming the results in the Cos-7
cells (figure 3.1). No additional plasma membrane staining was observed for CD4-
Pen2TMD1. This could be due to more modest expression in the stably transfected
Swe cells.
Next, deglycosylation assay was performed to asses the localisation of the CD4 re-
porter proteins in the secretory pathway. The oligosaccharides of N-glycosylated pro-
teins are sensitive to cleavage by Endoglycosidase H (EndoH) before they reach me-
dial Golgi cisternae. There, they can be modified by N-acetylglucosamine-transfer-
ases and Mannosidases I and II resulting in a resistance against cleavage by EndoH
(Dalbey and Heijne, 2002). Hence, ER retention causes EndoH-sensitivity whereas
transport to the plasma membrane can result in EndoH-resistance of the oligosaccha-
rides of the CD4 reporter protein. In case of CD4 only one of the two glycosylation
sites becomes EndoH-resistant during the maturation of the protein (Nilsson et al.,
1989). To perform the assay, CD4 protein was immunoprecipitated from STEN
lysates of Swe cells stably expressing the respective CD4 reporter protein. The eluted
protein was split into three parts and either left untreated, treated with EndoH or
N-glycosidase F (NGF). After the treatment the CD4 protein was precipitated and
separated by SDS-PAGE. A Western blot of a deglycosylation assay is shown in Fig-
∅ H F
CD4-Pen2TMD1
∅ H F
CD4-RXR
∅ H F
CD4
Figure 3.3: Deglycosylation assay substantiated ER retention of CD4-Pen2TMD1. CD4
protein was immunoprecipitated from lysates of Swe cells stably expressing
the respective CD4 species. The IP eluates were split into 3 parts and were
either left untreated (Ø), treated with Endoglycosidase H (H) or treated with
N-glycosidase F (F). The triangle indicates EndoH-resistant species and the
star EndoH-sensitive species.
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ure 3.3. A slightly faster mobility was observed even for the PM-localised CD4 after
EndoH-treatment, because one glycosylation site stays permanently EndoH sensi-
tive. In contrast, NGF cleaved off all N-glycosylations, yielding the naked protein.
Thus, NGF-treated CD4 migrated even faster than EndoH-treated CD4, resulting
in the typical stair-like pattern, characteristic for CD4 species that reached later
Golgi cisternae (figure 3.3, left lanes). CD4-RXR was EndoH-sensitive. Treatment
of CD4-RXR with EndoH or NGF led to equally fast mobilities, showing that CD4-
RXR stayed in early compartments of the secretory pathway. The band pattern for
CD4-Pen2TMD1 was indistinguishable from CD4-RXR clearly demonstrating that
CD4-Pen2TMD1 was retained in the ER.
3.1.2 FACS-based quantification of ER retention
To asses ER retention in a quantitative manner a FACS-based localisation assay
was developed. Briefly, Swe cells stably expressing the respective CD4 reporter
protein were stained with an anti-CD4-APC antibody. After the staining of the
surface antigens, cells were fixed, permeabilised and each sample was split into two
parts. To obtain a sample which has the total CD4 antigens stained, one part was
stained a second time with the same anti-CD4-APC antibody to label intracellular
CD4 antigens. Subsequently, cells were measured by FACS and single intact cells
were gated by size (FSC) and granularity (SSC) in several steps as indicated in
figure 3.4. The obtained histogram plots for APC intensities of a representative
experiment are shown in the right part of figure 3.4. Although the peaks for totally
stained Swe cells stably expressing CD4 and CD4-Pen2TMD1 were approximately
equal, Swe CD4-Pen2TMD1 cells showed much less surface fluorescence than Swe
CD4 cells.
The geometric mean of the fluorescence intensities was used to quantify the
amount of plasma membrane or total CD4 antigen. As depicted in figure 3.5, in
Swe cells 53.8 % of the stably expressed CD4 was at the plasma membrane. In
contrast, after the fusion of the cytoplasmic RXR retention signal to CD4 only 4.9
% of this CD4 construct was at the plasma membrane. Swe cells stably expressing
CD4-Pen2TMD1 have 4.0 % of surface CD4, again confirming a strong intracellular
retention of CD4-Pen2TMD1.
Taken together, the results confirmed the initial findings of an ER retention signal
in the TMD1 of Pen2. The signal could be transferred to a reporter protein and the
conferred ER retention was independent of the cell line used. The combination of
FACS analysis with a protocol for the staining of intracellular antigens resulted in
an assay which allowed quantification of ER retention.
3.1.3 The ER retention signal in Pen2-TMD1 contributes
to the stability of Pen2
The first described ER retention signals in TMDs were based on charged residues
within the hydrophobic environment of a TMD. These signals intimately coupled the
processes of degradation and ER retention (Bonifacino et al., 1990a,b; Letourneur
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Figure 3.4: Gating scheme for the FACS analysis of stable Swe cell lines. Swe cell
lines stably expressing the respective CD4 species were fixed and stained for
either surface or total CD4 antigen. Intact cells were gated via several steps
of FSC and SSC gating. The populations used for the measurement of the
APC signal are shown in the histogram plots to the right. The percentage of
all measured cells that display a distinct fluorescence intensity (% of Max)
is plotted against the fluorescence intensity. The APC-A signal reflects the
amount of CD4 antigen.
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Figure 3.5: Quantification of surface CD4 antigen confirmed ER retention of CD4-
Pen2TMD1. Swe cell lines stably expressing the respective CD4 species were
either stained for surface CD4 or for total CD4 after permeabilisation. Cells
were measured by FACS and the geometric mean of the fluorescence intensi-
ties was determined. The ratios of surface CD4 to total CD4 were calculated
for the respective CD4 variants. The error bars depict the standard error
of n=4-5 experiments.
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Figure 3.6: The ER retention signal in Pen2-TMD1 contributed to the stability of Pen2.
A) Scheme of the Pen2-TMD1 and the generated mutants in GFP-Pen2
B) PSDKO cells were transiently transfected with GFP-Pen2 variants as
indicated or were left untreated (mock). 12 hours later cells were treated with
100 µg/ml cycloheximide (CHX) for the indicated time span. Subsequently,
cells were lysed, subjected to immunoprecipitation with a rabbit anti-GFP
antibody and the eluates were analysed by Western blot. The figure shows
a shorter and a longer exposure of the same blot.
et al., 1995). Data from our lab revealed that the identified ER retention signal in
the Pen2-TMD1 depended on a critical asparagine (Kaether et al., 2007). For this
reason, it was tested if a similar mechanism caused the rapid degradation of Pen2
with its polar asparagine in the TMD1.
To this end, N-terminally EGFP-tagged Pen2 was constructed (GFP-Pen2).
Data from our lab demonstrated that GFP-Pen2 was fully functional and completely
rescued stable Pen2 knock down by shRNA (Johanna Scheuermann, published in
Fassler et al., 2009). Subsequently, three different mutations were introduced. The
asparagine important for ER retention (GFP-Pen2N/L) as well as the asparagine
and the two adjacent residues (GFP-Pen23L) were mutated to leucine. Additionally,
the 9 most C-terminal amino acids of the Pen2-TMD1 were exchanged with the cor-
responding sequence from the CD4-TMD (GFP-Pen2CD4)(Johanna Scheuermann).
The TMDs of all constructs are summarised in figure 3.6A. All constructs were tran-
siently transfected into PSDKO cells. Thus, no interaction with PS could cause a
stabilisation or destabilisation of the GFP-Pen2 variants. After 12 hours cells were
treated with cycloheximide for different time spans. Subsequently, the stability of
the different GFP-Pen2 was analysed by Western blot.
Consistent with earlier findings, GFP-Pen2 was instable and strongly reduced
after 6 hours (Bergman et al., 2004a)(figure 3.6B). Nevertheless, wildtype GFP-
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Pen2 was more stable than the GFP-Pen2 variants that were lacking the polar
asparagine. Thus, the asparagine confers relative stability to wildtype Pen2 when
compared with the other GFP-Pen2 mutants. The observed difference in stability
was not due to overall misfolding of the protein, since at least GFP-Pen2N/L and
GFP-Pen23L assembled into an active γ-secretase complex in other experiments
(Johanna Scheuermann, published in Fassler et al., 2009).
3.2 PS1-TMD4 contains an ER retention signal
In the previous chapter it was shown that the TMD1 of Pen2 harbours an ER
retention signal, which depended on a critical asparagine residue (see also Kaether
et al., 2007). In a next step, other potential ER retention signals within the γ-
secretase complex should be investigated. Two publications by Kim and Sisodia,
2005a and Watanabe et al., 2005 drew the attention to the PS1-TMD4 that was
described to contain a binding site for Pen2. This binding site was composed of
a WNF motif. The presence of an asparagine within the PS1-TMD4 raised the
question, if this asparagine might also constitute an ER retention signal.
3.2.1 PS1-TMD4 confers ER retention to reporter proteins
Similar to the analysis of the Pen2-TMD1, a CD4 reporter protein was con-
structed which had its TMD exchanged against the TMD4 of human PS1 (CD4-
PS1TMD4). Moreover, the WNF motif described in Watanabe et al. (2005) was
mutated to AAA to assess its contribution to a potential retention signal (CD4-
PS1TMD4mut). As controls the described CD4 and CD4-RXR constructs were used.
All constructs were schematised in figure 3.7A,B.
CD4, CD4-RXR, CD4-PS1TMD4 and CD4-PS1TMD4mut were transiently trans-
fected into Cos-7 cells grown on cover slips. Immunocytochemistry with anti-CD4
and anti-BiP antibodies revealed ER localisation for CD4-PS1TMD4, as was demon-
strated by the colocalisation of CD4 staining with the ER marker BiP (figure 3.7C,
third column). The introduction of the WNFAAA mutation caused partial abro-
gation of ER retention and a mixed pattern of plasma membrane and ER staining
was visible (figure 3.7C, fourth column).
To confirm this results, Swe cell lines stably expressing CD4-PS1TMD4 and
CD4-PS1TMD4mut were generated. As a control, the described Swe CD4 and Swe
CD4-RXR cell lines were used. Cells were grown on cover slips and prepared for
immunofluorescence using anti-CD4 and anti-Calreticulin antibodies. Microscopy
was carried out on a Zeiss Axio Imager with the ApoTome slider module, allow-
ing confocal-like optical sections through the Swe cells. The ER localisation of
CD4-PS1TMD4 could be confirmed (figure 3.8, third column) and CD4-PS1TMD4mut
showed a mixed distribution between plasma membrane and ER (nuclear envelop)
similar to the observations in Cos-7 cells.
Next, deglycosylation assay was performed to obtain further evidence for the
ER localisation of CD4-PS1TMD4. To this end, lysates of the stable Swe CD4, Swe
CD4-RXR, Swe CD4-PS1TMD4 and Swe CD4-PS1TMD4mut cell lines were used in the
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Figure 3.7: CD4-PS1TMD4 was retained in the ER in Cos-7 cells. A) Constructed CD4
variants. B) Comparison of the TMD regions of the CD4 constructs. C)
Cos-7 cells were transiently transfected with different CD4 variants. Cells
were subjected to immunofluorescence staining with antibodies against CD4
and the ER marker BiP. Nuclei were stained with DAPI and cells were anal-
ysed by fluorescence microscopy. In the merge pictures CD4 was coloured
red, BiP green and DAPI blue. Scalebar 10 µm. The lower panel shows mag-
nifications (magnif.) of the boxed areas above. Scalebar 2 µm. Arrowheads,
PM localisation; Arrows, ER localisation (nuclear envelope and reticular
ER).
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Figure 3.8: CD4-PS1TMD4 was retained in the ER in Swe cells. Swe cells stably ex-
pressing CD4 variants as indicated were subjected to immunofluorescence
staining with antibodies against CD4 and the ER marker Calreticulin. Nu-
clei were stained with DAPI. Pictures show optical sections obtained by flu-
orescence microscopy with an apotome slider module. In the merge picture
CD4 was coloured red, Calreticulin green and DAPI blue. Arrowheads, PM
localisation; Arrows, ER localisation (nuclear envelope and reticular ER);
Scalebar 10 µm.
assay. As expected, CD4 was EndoH-resistant and CD4-RXR was EndoH-sensitive
(figure 3.9, first and second column). CD4-PS1TMD4 displayed EndoH-sensitivity
indicating a localisation in the early secretory pathway (ER or cis-Golgi)(figure 3.9,
third column). In contrast, CD4-PS1TMD4mut showed a mix of EndoH-sensitive and
EndoH-resistant CD4 molecules, which resulted in a double band in the EndoH-
treated sample (figure 3.9, fourth column, lane H). This result suggested a partial
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Figure 3.9: Deglycosylation assay substantiated ER retention of CD4-PS1TMD4. CD4
protein was immunoprecipitated from lysates of Swe cells stably expressing
the respective CD4 species. The IP eluates were split into 3 parts and were
either left untreated (Ø), treated with Endoglycosidase H (H) or treated with
N-glycosidase F (F). The triangle indicates endoH resistant species and the
star endoH sensitive species.
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Figure 3.10: Quantification of surface CD4 antigen confirmed ER retention of CD4-
PS1TMD4 and showed a partial release of CD4-PS1TMD4mut. Swe cell
lines stably expressing the respective CD4 species were either stained for
surface CD4 or for total CD4 after permeabilisation. Cells were measured
by FACS and the geometric mean of the fluorescence intensities was de-
termined. The ratios of surface CD4 to total CD4 were calculated for the
respective CD4 variants. The two controls CD4 and CD4-RXR are iden-
tical to the data shown in 3.5. The error bars depict the standard error of
n=4-6 experiments.
release of CD4-PS1TMD4mut from the ER to later compartments of the secretory
pathway, which perfectly matched the observations by immunofluorescence.
To quantify the ER retention of the different CD4 species the described FACS-
based localisation assay was performed (chapters 3.1.2 and 2.5). In Swe cells stably
expressing CD4 and CD4-RXR 53.8 % and 4.9 % of the CD4 antigen was at the
cell surface, respectively. In Swe CD4-PS1TMD4 cells 8.1 % of the CD4 antigen was
located at the plasma membrane, demonstrating intracellular retention in the range
of CD4-RXR. In contrast, in Swe cells stably expressing CD4-PS1TMD4mut a highly
significant increase to 16.3 % of surface CD4 was observed (figure 3.10). This again
mirrored the results obtained by immunocytochemistry and the deglycosylation as-
say, since the introduced mutation did not lead to a complete release of the CD4
antigen to the cell surface.
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In addition to the CD4 constructs, mouse Tac reporter proteins were constructed.
Mature mouse Tac, also known as mouse interleukin-2 receptor, is a 55 kDa trans-
membrane glycoprotein with a type I topology. Tac is by default rapidly transported
to the plasma membrane (Bonifacino et al., 1990b) and it was used before to analyse
TMD-based ER retention signals in TCRα and the nicotinic acetylcholine receptor
(Bonifacino et al., 1990a; Wang et al., 2002). To analyse an ER retention signal
in the PS1-TMD4, the TMD of Tac was replaced with the TMD4 of human PS1
(Tac-PS1TMD4) and a Tac-RXR was constructed for control. Tac-RXR was con-
structed similarly to CD4-RXR, by fusing the last 36 amino acids of Kir6.2 to the
Tac C-terminus, thus introducing a cytoplasmic RXR retention motif (Zerangue
et al., 1999). The Tac constructs and a comparison of the respective TMD regions
TME NVAVDYITVALLIWNFGVVGMISI QHR Tac-PS1TMD4
TME ALIVLGGVAGLLLFIGLGIFFCV  QHR Tac
TacTMDTac
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Tac CTac TacTac-TMDN
Tac-PS1TMD4 CTac TacPS1-TMD4N
Tac-RXR RXR CTac TacTac-TMDN
Figure 3.11: Tac-PS1TMD4 was retained in the ER in Cos-7 cells. A) Constructed Tac
variants. B) Comparison of the TMD regions of the Tac constructs. C)
Cos-7 cells were transiently transfected with different Tac variants. Cells
were subjected to immunofluorescence staining with antibodies against Tac
and nuclei were stained with DAPI. Cells were analysed by fluorescence
microscopy. Arrowheads, PM localisation; Arrows, ER localisation (nu-
clear envelope and reticular ER); Scalebar 10 µm.
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are shown in figure 3.11A,B.
Tac, Tac-RXR and Tac-PS1TMD4 were transiently transfected into Cos-7 cells
grown on cover slips. Subsequently, cells were processed for immunocytochemistry
with anti-Tac antibodies. As expected, Tac was localised to the plasma membrane,
whereas Tac-RXR was retained in the ER (figure 3.11C, first and second column).
Tac-PS1TMD4 was also localised to ER, supporting the preceding findings of an ER
retention signal within the PS1-TMD4.
In conclusion, it was clearly demonstrated that the TMD4 of PS1 contained an
ER retention signal, which could confer ER retention to different reporter proteins.
Since reporter proteins were retained in the ER in Swe, Cos-7, HeLa Kyoto and
NIH3T3 cells (data not shown for the latter two), the retention signal was cell
line independent. The WNF sequence in the PS1-TMD4 which was implicated
in the binding of Pen2 to PS1 (Watanabe et al., 2005; Kim and Sisodia, 2005a)
strongly contributed to the retention signal. Nevertheless, other amino acids of the
PS1-TMD4 likely contribute to the ER retention signal, because the WNFAAA
mutation did not lead to a complete ER release of the CD4-PS1TMD4mut reporter
protein.
3.2.2 Relevance of PS1-TMD4 for the ER retention of full-
length PS1
In the previous section evidence was given on the presence of an ER retention
signal in the PS-TMD4. The relevance of the identified signal for the full-length
presenilins remained unclear. Furthermore, Kaether et al., 2004 published another
ER retention signal within the PS1-TMD9, that depended on a PALP motif. The
presence of two retention signals on one protein raised the question, if both were
necessary to obtain ER retention of PS1.
To address this concern, a series of mutants of PS1-EGFP (PE) were constructed,
which had either a WNFAAA mutation (PE−WNF ) or a PALPAAAA (PE−PALP )
mutation or both retention signals mutated (PE−PALP−WNF ). HeLa Kyoto cell lines
were generated that stably expressed the four PE variants. The stably expressing
cells were seeded onto cover slips and subsequently subjected to immunocytochem-
istry with anti-GFP and anti-Calnexin antibodies.
PE was located at the plasma membrane (figure 3.12, column 1), although two
ER retention signals were present (WNF and PALP). The reason for this observation
was the incorporation of PE into fully functional γ-secretase complexes, which were
transported to the plasma membrane (Kaether et al., 2004). The absence of ER-
located PE molecules indicated that the expression levels were modest, because no
unassembled, excessive PE accumulated in the ER. The localisation of PE−PALP
was indistinguishable from PE (figure 3.12, column 2). PE−PALP also assembled
into complete γ-secretase complexes, although these complexes stayed catalytically
inactive. However, the observed lack of activity did not interfere with the trafficking
of the assembled γ-secretase (Kaether et al., 2004).
PE−WNF displayed a clear ER staining, nicely overlapping with the ER marker
Calnexin (figure 3.12, column 3). In contrast to the PE−PALP mutant, Pen2 could
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Figure 3.12: Mutagenesis of two ER retention signals did not cause ER export of
PS1-EGFP (PE). HeLa Kyoto cells stably expressing PE and different
mutants were subjected to immunofluorescence staining with antibodies
against GFP and the ER marker Calnexin. Nuclei were stained with DAPI
and cells were analysed by fluorescence microscopy. In the merge pictures
GFP was coloured green, Calnexin red and DAPI blue. Scalebar 10 µm.
The lower panel shows magnifications (magnif.) of the boxed areas above.
Scalebar 2 µm. Arrowheads, PM localisation; Arrows, ER localisation (nu-
clear envelope and reticular ER). The models at the bottom indicate the
assembly state of the γ-secretase complex in the respective cell line (modi-
fied after Steiner et al., 2008b). Most of the observed GFP-derived fluores-
cence originated from PE molecules that were assembled into the depicted
complexes.
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no longer bind to the trimeric assembly intermediate composed of Aph-1, Nct and
PE−WNF (see figure 3.12, bottom)(Watanabe et al., 2005; Kim and Sisodia, 2005a).
Since the incorporation of Pen2 was the last and rate limiting step during γ-secretase
assembly (Takasugi et al., 2003; Prokop et al., 2004), the expressed PE−WNF ac-
cumulated in this immature, trimeric complex intermediate. The double mutant
PE−PALP−WNF demonstrated the same ER staining like PE−WNF (figure 3.12, col-
umn 4). Due to the WNFAAA mutation, PE−PALP−WNF was trapped in the same
assembly state like PE−WNF . The observation of ER retention for PE−PALP−WNF
disclosed the presence of further open ER retention signals besides PALP and WNF
in the trimer.
In the experimental approach used here, the stable, low level expression of PE and
its mutants probably led to a steady state with almost no free PE. This was suggested
by the lack of an ER staining in the HeLa Kyoto cells stably expressing PE. Newly
synthesised PE was immediately bound by Nct/Aph-1 heterodimers and a complete
γ-secretase complex was formed and transported to the plasma membrane. The
expression levels in the other HeLa Kyoto cell lines stably expressing the different
PE mutants were similar, suggesting that PE molecules are also bound by Nct/Aph-1
heterodimers in these cells. This situation complicated the analysis of the potency
of different ER retention signals in PS1, since retention signals on other γ-secretase
subunits might have interfered with the signals known in PS1. For example, Spasic
et al., 2007 described an ER retention signal in the TMD of Nct, although this signal
could not be confirmed in experiments in our lab (Christina Valkova, unpublished
data). In summary, it turned out to be of great importance to consider the assembly
state of γ-secretase during the analysis of the strength of ER retention signals on
one complex subunit.
To exclude the potential influence of ER retention signals on other γ-secretase
subunits an assembly mutant of PE was constructed. To this end, the 7 most C-
terminal amino acids of all four described PE variants were deleted, giving rise to
PE∆7 and the respective mutants. PE∆7 lacked the binding site for Nct (Kaether
et al., 2004; Bergman et al., 2004b) and is not incorporated in any assembly inter-
mediates. Thus, it was possible to analyse the ER retention of PE and its mutants
in an isolated manner.
The four PE∆7 species were stably expressed in HeLa Kyoto cells. The stable
cells were seeded onto cover slips, stained with an anti-GFP antibody and analysed
by fluorescence microscopy. All four species clearly localised to the ER. Even in
PE∆7−PALP−WNF that lacked both known retention signals and had no contact to
other subunits, exclusively ER staining was visible (figure 3.13). This observation
provided direct evidence on the presence of a third or even fourth ER retention
signal within PS1. Hence, an ultimate answer on the relevance of the novel ER
retention signal in the PS1-TMD4 for full-length PS1 could not be given.
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Figure 3.13: PS1-EGFP ∆7 (PE ∆7) and its mutants were retained in the ER. HeLa
Kyoto cells stably expressing PE ∆7 and the indicated mutants were sub-
jected to immunofluorescence staining with antibodies against GFP and
nuclei were stained with DAPI. Subsequently cells were analysed by fluores-
cence microscopy. Arrows, ER localisation (nuclear envelope and reticular
ER); Scalebar 10 µm.
3.3 Rer1-dependency of TMD-based retention signals
Though it has been clear since many years that TMD-based ER retention signals
do exist (Bonifacino et al., 1991) only little was known how these signals function
in detail and which other proteins were involved in this process. In yeast, Rer1p
was described as a retrieval receptor for ER localised proteins and it recognised its
target proteins via polar residues in their TMDs (Sato et al., 1995, 1996). In table
3.1 a selection of Rer1p target proteins together with the respective signal-containing
TMD is shown. These TMDs were compared to the TMDs of γ-secretase subunits
Pen2, Nct and PS1, in which ER retention signals were identified (this work and
Spasic et al., 2007). The only common feature of all Rer1p substrates in yeast were
one or more polar residues in the hydrophobic context of a TMD. This criteria was
met by the ER retention signals in the PS1-TMD4 and the Pen2-TMD1 for which
reason it was tested if mammalian Rer1 was involved in the retention of PS1 and/or
Pen2.
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Table 3.1: By analogy Pen2 and PS1 could be substrates of Rer1. Comparison of the
TMDs of confirmed substrates of Rer1p from yeast with the potential mam-
malian substrates Nct, Pen2 and PS1. Residues which are important for the
(Rer1-mediated) ER retention are underlined.
protein TMD sequence topology type reference
Sec12p LSFQLIYSLLVILIFNTFF II
Sato et al., 1995
Sato et al., 1996
Sec71p ISVYTPLIYVFILVVSLVMFASSY III
Sato et al., 1997
Sato et al., 2003
Fet3p IIAMTFSCFAGILGIITIAIYGMM I Sato et al., 2004
Nct LITLTVGFGILIFSLIVTYCI I Spasic et al., 2007
Pen2-TMD1 YYLGGFAFLPFLWLVNIFWFF IV-B
this study
PS1-TMD4 NVAVDYITVALLIWNFGVVGMISI IV-A
3.3.1 Rer1 binds to unassembled Pen2 via the Pen2-TMD1
To test if Rer1 can directly bind to the TMD1 of Pen2 a set of double stable Swe
cell lines were generated that all expressed C-terminally V5-tagged Rer1 plus either
CD4, CD4-Pen2TMD1 or CD4-Pen2TMD1mut. CD4-Pen2TMD1mut contained a NL
mutation in the Pen2-TMD1, which was shown to partially abrogate ER retention
of the CD4 reporter (Kaether et al., 2007). After IP with an anti-V5 antibody only
CD4-Pen2TMD1 co-immunoprecipitated with Rer1-V5 from CHAPSO lysates. In
contrast, CD4-Pen2TMD1mut did not co-immunoprecipitate with Rer1-V5, suggesting
that the mutated asparagine was important for the binding to Rer1 (figure 3.14).
In the next step it was tested if Rer1 also binds to the full-length protein and
if it binds to free or complex-associated Pen2. To this end, two stable Swe cell
lines were created, one expressing N-terminally myc-tagged Pen2 (mycPen2) alone,
while the second expressed mycPen2 together with Rer1-V5. CHAPSO lysates of
these cells were subjected to two subsequent immunoprecipitations with anti-V5
and anti-myc antibodies, respectively. The first IP of Rer1-V5 showed specific co-
immunoprecipitation of mycPen2, but of no other γ-secretase component (figure
3.15, left lanes). From the supernatant of the first immunoprecipitation mycPen2
was immunoprecipitated together with robust amounts of the other components of
mature γ-secretase (Aph-1, mature Nct, PS1-NTF), confirming that the majority
of Pen2 in the cells was incorporated into the mature complex (figure 3.15, right
lanes). In the second immunoprecipitation with anti-myc antibodies also Rer1-V5
co-immunoprecipitated. However, it was shown in other experiments that this was
due to unspecific binding of Rer1-V5 to the sepharose beads (data not shown).
The co-immunoprecipitation of mycPen2 with the other γ-secretase components
demonstrated that the complex stayed intact under the conditions during immuno-
precipitation. Together with the absence of Nct, Aph-1 and PS1 in the Rer1-V5
immunoprecipitation this suggested that Rer1-V5 selectively bound to unassembled
mycPen2. This binding depended on a binding site in the Pen2-TMD1, which was
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most probably inaccessible for Rer1-V5 in the assembled γ-secretase complex.
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Figure 3.14: CD4-Pen2TMD1 co-immunoprecipitated with Rer1-V5. Rer1-V5 was im-
munoprecipitated from CHAPSO lysates of Swe cells expressing either
Rer1-V5 alone or together with the indicated CD4 variant. After Western
blot the proteins were detected with anti-V5 antibody or anti-CD4 anti-
body. Expression of CD4 species was analysed by IP and Western blot
using anti-CD4 antibodies. Data kindly provided by Christoph Kaether.
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Figure 3.15: Rer1 selectively bound to unassembled Pen2. CHAPSO lysates of Swe
cells stably expressing mycPen2 either alone or together with Rer1-V5 were
subjected to two subsequent immunoprecipitations with anti-V5 and anti-
myc antibodies, respectively. Immunoprecipitation eluates were analysed
by Western blot with antibodies against V5, myc, Nct, Aph-1 and PS1-
NTF. The white lines indicate the assembly from different areas of the
same blot.
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3.3.2 ER retention of CD4-Pen2TMD1 but not CD4-PS1TMD4
depends on Rer1
After the demonstration of a direct interaction of the overexpressed proteins it
was next tested if that interaction is of functional relevance. To this end, the FACS-
based quantification of ER retention described in chapter 3.1.2 was combined with
a siRNA approach.
In a first step the delivery of and the knock down by siRNA in Swe cells
was validated. The transfection efficiency of siRNA was analysed using an Alexa
Fluor
®
488-conjugated, non-targeting siRNA. 6 hours post-transfection control- or
siRNA-transfected cells were analysed by FACS, revealing a transfection of virtu-
ally all cells (figure 3.16A). In the next step, the same transfection conditions were
used to knock down Rer1 in Swe cells. In figure 3.16B Swe CD4 cells were transfected
with control- or Rer1-siRNA. After 24, 48 and 72 hours the Rer1 and CD4 protein
levels were analysed by Western blot. A robust knock-down could be observed after
48 and 72 hours with no change in the levels of CD4 protein. These results were
reproduced for all stable Swe cell lines, independent of the expressed CD4 variant
(data not shown).
As a result from the knock down optimisation the 72 hour time point was chosen
for the analysis of Rer1-dependency of the TMD-based retention signals. Stable Swe
cells that express CD4, CD4-RXR, CD4-Pen2TMD1 or CD4-PS1TMD4 were used in
the assay. Swe CD4 cells were not transfected with any siRNA, serving as a (the-
oretical) endpoint in the assay by depicting the maximum of surface CD4. Swe
CD4-RXR cells served as a negative control, since the RXR retention signal de-
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Figure 3.16: siRNA was efficiently transfected into Swe cells and caused robust Rer1
knock down. A) Swe cells stably expressing CD4 were either transfected
with Alexa Fluor®488-labelled siRNA or left untreated. Transfection effi-
ciency was measured after 6 hours by FACS analysis. The percentage of
all measured cells that display a distinct fluorescence intensity (% of Max)
is plotted against the fluorescence intensity. B) Swe cells stably expressing
CD4 were transfected either with Rer1- or control-siRNA. STEN lysates
of transfected cells were prepared after 24 h, 48 h and 72 h and analysed
by Western blot for protein levels of CD4 and Rer1. Actin was used as an
internal loading control.
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Figure 3.17: Scheme for the combination of the FACS-based quantification assay with
Rer1 knock down. Swe cells stably expressing different CD4 variants were
transfected with Rer1-siRNA, control-siRNA or left untransfected (not
shown here). After 72 hours cells were prepared and measured as described
in chapter 3.1.2 and figure 3.4. Shown here are histograms of only surface
stained samples. The percentage of all measured cells that display a dis-
tinct fluorescence intensity (% of Max) is plotted against the fluorescence
intensity. APC-A reflects the amount of surface CD4. Note the increasing
amount of surface CD4 for the Swe CD4-Pen2TMD1 in the Rer1-siRNA
transfected sample (green arrow).
pended on other proteins but Rer1 (Yuan et al., 2003; Nufer and Hauri, 2003). Swe
CD4-RXR, CD4-Pen2TMD1 and CD4-PS1TMD4 were either left untransfected, trans-
fected with control-siRNA or transfected with Rer1-siRNA. After 72 hours cells were
harvested, counted and each sample was split into two subsamples of defined cell
number. The subsamples were either stained for total CD4 antigen or for surface
CD4 antigen as has been described earlier (chapter 3.1.2). All stained samples were
measured by FACS analysis and the fraction of surface CD4 was calculated from
the fluorescence. Figure 3.17 schematises the experiment. The histograms show the
surface CD4 immunoreactivity in cells treated with control- or Rer1-siRNA. It is
clearly visible that after Rer1 knock down the amount of surface CD4 increased in
Swe CD4-Pen2TMD1 cells (green arrow).
Swe CD4-RXR, CD4-Pen2TMD1 and CD4-PS1TMD4 cells displayed strong ER
retention of the respective CD4 variant under non-treated or control-siRNA condi-
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Figure 3.18: Rer1 knock down caused the release of CD4-Pen2TMD1 but not CD4-
PS1TMD4 towards the cell surface. Swe cell lines stably expressing the
respective CD4 species were either left untreated, transfected with control-
siRNA or with Rer1-siRNA. After 72 hours cells were either stained for
surface CD4 or for total CD4 after permeabilisation. Cells were measured
by FACS and the geometric mean of the fluorescence intensities was de-
termined. The ratios of surface CD4 to total CD4 were calculated for the
respective conditions and CD4 variants. The data for the Swe CD4 cells
are identical to the data shown in figure 3.5. The error bars depict the
standard error of n=3-4 experiments.
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Figure 3.19: C-terminally EGFP-tagged CD4-Pen2TMD1 (CD4-Pen2TMD1-EGFP)
was retained in the ER. A) Cos-7 cells transiently expressing CD4-
Pen2TMD1-EGFP and HeLa Kyoto cells stably expressing CD4-
Pen2TMD1-EGFP were fixed and nuclei were stained with DAPI. Subse-
quently, cells were analysed by fluorescence microscopy. Scalebar 10 µm.
Arrows, ER localisation (nuclear envelope and reticular ER). B) Lysates
of CHO cells stably expressing CD4-Pen2TMD1-EGFP were used for a
deglycosylation assay. Star indicates endoH sensitive species.
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tions. After Rer1 knock down only CD4-Pen2TMD1 showed a significant increase of
surface CD4 levels. The percentage of surface CD4 immunoreactivity increased by
a factor of 2.7 from 5.9 % to 16.1 % (figure 3.18). This result demonstrated the
functional relevance of Rer1 for the ER retention signal in the Pen2-TMD1, whereas
the ER localisation of the PS1-TMD4 was Rer1-independent.
The Rer1-dependence of CD4-Pen2TMD1 retention was confirmed using fluores-
cence microscopy. To this end, CD4-Pen2TMD1 with a C-terminally fused EGFP
moiety was constructed. CD4-Pen2TMD1-EGFP localised to the ER in transiently
transfected Cos-7 cells and stably expressing HeLa Kyoto cells as demonstrated by
the strong staining of the nuclear envelope (figure 3.19A). In the stable HeLa Kyoto
cells some additional plasma membrane staining is visible due to the high expres-
sion level in this cell line. Moreover, CD4-Pen2TMD1-EGFP stably expressed in
CHO cells showed endoH sensitivity in a deglycosylation assay, confirming the ER
retention observed by fluorescence microscopy (figure 3.19B).
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Figure 3.20: CD4-Pen2TMD1-EGFP was released to the cell surface after Rer1 knock
down. HeLa Kyoto CD4-Pen2TMD1-EGFP cells were seeded onto cover
slips and transfected with siRNA or left untreated as indicated. 72 hours
later cells were stained for surface CD4, fixed and the nuclei were stained
with DAPI. All pictures were taken with identical exposure times and
equally processed with Photoshop software. In the merge picture surface
CD4 was coloured red, EGFP green and DAPI blue. Arrowheads, PM lo-
calisation; Arrows, ER localisation (nuclear envelope and reticular ER);
Scalebar 10 µm.
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Similar to the FACS-based assay, the HeLa Kyoto cells stably expressing CD4-
Pen2TMD1-EGFP were either left untreated or transfected with control- and Rer1-
siRNA, respectively. After 72 hours cells were processed for immunofluorescence
staining of surface CD4 using an anti-CD4 antibody prior to fixation and perme-
abilisation. Thus, it is possible to compare surface CD4 levels with total CD4-
Pen2TMD1-EGFP expression, which is reflected by the EGFP signal. In figure 3.20
both siRNA-transfected samples displayed equal EGFP signals, whereas the surface
CD4 signal was much stronger in the Rer1 knock down cells (second and third col-
umn, respectively). On the other hand, untreated cells showed some surface CD4
(though not as much as Rer1 knock down cells), but they also displayed an increased
EGFP signal.
The effect of Rer1 knock down on the localisation of CD4-Pen2TMD1-EGFP
was quantified using automated microscopy and image analysis in a 96-well plate
scale (see 2.4.1 for details). Briefly, pictures of the Alexa Fluor
®
555, EGFP and
DAPI channels were automatically taken with equal exposure times. The software
subsequently identified cells via the DAPI staining and expanded the nucleus by 7
pixels, thus creating a region of interest for the quantification. Within this region
of interest the intensities of the Alexa Fluor
®
555 signal (reflecting surface CD4-
Pen2TMD1-EGFP) and the EGFP signal (reflecting total CD4-Pen2TMD1-EGFP)
were measured and the ratio was calculated (figure 3.21, left part). This ratio
increased highly significantly from 0.76 for cells transfected with control-siRNA to
1.74 in Rer1 knock down cells (figure 3.21, right part). The obtained results perfectly
matched the data obtained in the FACS assay (figure 3.18).
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Figure 3.21: Rer1 knock down triggered the release of CD4-Pen2TMD1-EGFP towards
the cell surface as revealed by quantitative immunofluorescence. HeLa Ky-
oto CD4-Pen2TMD1-EGFP cells were seeded into 96-well plates and trans-
fected with siRNA or left untreated as indicated. 72 hours later cells were
stained for surface CD4, fixed and the nuclei were stained with DAPI.
Using Cellomics ArrayScan HCS reader and Cellomics One software cel-
lular structures were identified automatically and a region of interest was
generated by expansion of the nucleus (dotted ellipse). The average in-
tensities of EGFP- and surface CD4-derived fluorescence were quantified
within these regions of interest and ratios were calculated.
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To sum up, it became evident that the ER-retention signal in the Pen2-TMD1
depended on Rer1. Rer1 bound exclusively unassembled Pen2 and this binding was
mediated by the Pen2-TMD1 that contained a critical asparagine residue. Although
PS1-TMD4 also contained an ER retention signal with a critical asparagine, the ER
retention of the PS1-TMD4 was independent of Rer1.
3.4 Masking of ER retention signals in Pen2 and PS1
In the first two chapters evidence was presented that the Pen2-TMD1 and the
PS1-TMD4 contained ER retention signals. Additionally, it was shown in 2005 by
two research groups, that the PS1-TMD4 comprised the binding site for the Pen2
subunit. The binding site was narrowed down to a WNF(Watanabe et al., 2005) or
NFmotif (Kim and Sisodia, 2005a). Hence, within in the PS1-TMD4 the binding
site to Pen2 and an ER retention signal overlapped. On the other hand Kim and
Sisodia, 2005b gave evidence, that the Pen2-TMD1 is indispensable for the binding
of Pen2 to PS1, a finding that was supported by data from our lab (Christoph
Kaether, unpublished data). Thus, Pen2-TMD1 likewise contained an interaction
site and an ER retention signal. This led to the hypothesis that the Pen2-TMD1 and
the PS1-TMD4 could exert a dual function during γ-secretase assembly. On the one
hand, they could accomplish ER retention of the unassembled subunits or complex
intermediates. On the other hand they could serve as interaction sites between the
two subunits, thus promoting the last step in the assembly of the γ-secretase, namely
the binding of Pen2 to the trimer of Nct, PS1 and Aph-1. In the course of this last
step, the protein-protein interaction between the Pen2-TMD1 and the PS1-TMD4
could lead to the masking of the two ER-retention signals and thereby allow ER
export of fully assembled complex.
3.4.1 Co-expression of Pen2-TMD1 and PS1-TMD4 causes
mutual masking of ER retention signals
To test this hypothesis, the interaction of the Pen2-TMD1 and the PS1-TMD4
was examined in an isolated manner, since the analysis in the context of the entire
complex was confined by the presence of other ER retention signals elsewhere in the
γ-secretase complex. Hence, in a first approach C-terminally myc-tagged versions
of CD4-PS1TMD4 and CD4-RXR were generated by Michael Zocher from our lab.
The addition of a myc tag allowed the distinction of CD4-PS1TMD4-myc and CD4-
RXR-myc from CD4-Pen2TMD1-EGFP by fluorescence microscopy. The constructs
are depicted in figure 3.22A.
HeLa Kyoto cells stably expressing CD4-Pen2TMD1-EGFP were seeded onto
cover slips and transiently transfected with either CD4-RXR-myc or CD4-PS1TMD4-
myc. After fixation cells were stained with mouse anti-myc antibodies to visualise
transfected cells. The untransfected (myc negative) cells showed ER localisation of
CD4-Pen2TMD1-EGFP as was shown before (figure 3.19A). As a negative control
CD4-RXR-myc was used that contained the CD4-TMD, which was not supposed
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Figure 3.22: CD4-Pen2TMD1-EGFP was released to the cell surface after co-expres-
sion with CD4-PS1TMD4-myc. HeLa Kyoto cells stably expressing CD4-
Pen2TMD1-EGFP were seeded onto cover slips and transfected with CD4-
PS1TMD4-myc or CD4-RXR-myc as a negative control. Cells were pro-
cessed for immunofluorescence with an anti-myc antibody and nuclei were
stained with DAPI. Subsequently, cells were analysed by fluorescence mi-
croscopy. Transfected (myc positive) cells were marked with an asterisk.
Arrowheads, PM localisation; Arrows, ER localisation (nuclear envelope
and reticular ER); Scalebar 10 µm.
to interact with the Pen2-TMD1. As expected, cells co-expressing CD4-Pen2TMD1-
EGFP and CD4-RXR-myc did not show any plasma membrane localisation of nei-
ther construct (figure 3.22B, left column, asterisk-marked cells). In contrast, cells
co-expressing CD4-Pen2TMD1-EGFP and CD4-PS1TMD4-myc displayed a strong PM
staining (figure 3.22B, right column, asterisk-marked cell). Notably, both constructs
CD4-PS1TMD4-myc and CD4-Pen2TMD1-EGFP were partially localised to the PM
when they were co-expressed, demonstrating that both had overcome ER retention.
To confirm these results, the introduced Tac reporter proteins Tac-RXR and Tac-
PS1TMD4 were used. The use of Tac reporters rendered the myc-tagging of the tran-
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Figure 3.23: The amount of surface CD4 antigen increased in HeLa Kyoto CD4-
Pen2TMD1-EGFP cells after co-expression of Tac-PS1TMD4. HeLa Kyoto
cells stably expressing CD4-Pen2TMD1-EGFP were seeded onto cover slips
and transfected with Tac-PS1TMD4 or with Tac-RXR and mock vector as
negative controls. Surface CD4 antigen was stained prior to fixation using
an Alexa Fluore®660-conjugated secondary antibody. Subsequently, Tac
was stained with an Alexa Fluore®555-conjugated secondary antibody and
the nuclei were stained with DAPI. Transfected (Tac positive) cells were
marked with an asterisk. Arrowheads, PM localisation; Arrows, ER local-
isation (nuclear envelope and reticular ER); Scalebar 10 µm.
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siently transfected reporters unnecessary, since the Tac antigen was used as a trans-
fection marker. The used constructs are depicted in figure 3.23A. Additionally, the
use of Tac reporters permitted the staining of surface CD4 by immunocytochemistry.
This allowed a more sensitive view on the release of CD4-Pen2TMD1-EGFP towards
the cell surface, since the fluorescence of the surface localised CD4 was not biased
by the total CD4-Pen2TMD1-EGFP. HeLa Kyoto CD4-Pen2TMD1-EGFP cells were
seeded onto cover slips and transfected with mock vector, Tac-RXR or Tac-PS1TMD4,
respectively. Subsequently, cells were stained for surface CD4 prior to fixation using
an Alexa Fluor
®
660-conjugated secondary antibody. Additionally, Tac antigen was
stained after permeabilisation with an Alexa Fluor
®
555-conjugated secondary anti-
body. The EGFP signal served as an expression control, ruling out possible changes
in localisation due to altered expression of the stable CD4-Pen2TMD1-EGFP. Trans-
fection with a mock vector or Tac-RXR did not result in an increase of surface CD4
levels and Tac-RXR was retained in the ER as expected (figure 3.23B, upper and
middle row). In contrast, transfection of Tac-PS1TMD4 caused an increase of sur-
face CD4 antigen in the cells co-expressing the CD4 and the Tac reporter protein.
Moreover, Tac-PS1TMD4 likewise localised partially to the plasma membrane (figure
3.23B, lower row) in these cells, although it was nicely retained in the ER in Cos-7
cells when expressed alone (figure 3.11C).
3.4.2 Quantitative analysis of ER retention signal masking
To assess the effect of masking on the localisation of the reporter proteins in
a more quantitative way, a FACS-based assay was performed. To this end, Cos-7
cells were transfected with CD4-Pen2TMD1-EGFP, CD4-PS1TMD4-myc or both con-
structs together. After 16 hours of expression cells were counted and split into
two subsamples, which were stained for surface and total CD4 antigen, respectively.
Additionally, the intracellular myc epitope of CD4-PS1TMD4-myc was stained with
a polyclonal anti-myc antibody and a PE-conjugated secondary antibody. This
staining allowed gating on cells that expressed either CD4-PS1TMD4-myc (PE
+) or
CD4-Pen2TMD1-EGFP (GFP
+) or both reporter proteins together (PE+GFP+) (see
figure 3.24). This work was performed in collaboration with Michael Zocher from
our lab.
For all three populations (PE+, GFP+, PE+GFP+) the fraction of surface CD4
antigen was calculated from the fluorescence intensities of the total and surface
CD4 stained subsamples. In CD4-PS1TMD4-myc or CD4-Pen2TMD1-EGFP express-
ing cells only 6.9 % and 8.6 % of the CD4 reporter protein was at the cell surface,
respectively. This indicates strong ER retention as was shown before by immuno-
cytochemistry. In contrast, co-expression of both constructs caused the release of
14.0 % of total CD4 antigen to the cell surface. This constituted a significant 2-fold
increase of surface CD4 antigen levels (figure 3.25B). This increase was not result-
ing from an overall increase of total CD4 reporter proteins in the double transfected
cells as was shown by Western blot analysis (figure 3.25A).
Taken together the data provided evidence that the TMD-associated ER reten-
tion signals in the PS1-TMD4 and the Pen2-TMD1 overcame ER retention, when
they were co-expressed in the same cell. This effect was not due to an overloading
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of the ER retention machinery due to overexpression as was shown by figure 3.25A.
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Figure 3.24: Gating strategy for the FACS-based masking assay. Intact cells were gated
using several steps of FSC and SSC gating. The gates used to isolate single
positive or double positive cells are shown to the right. In this example co-
transfected cells are shown. The intensities of CD4 signals of the gated
cells were used to calculate the fraction of surface CD4 for the respective
subpopulation.
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Figure 3.25: Quantification confirmed increased surface CD4 levels after co-expression
of CD4-Pen2TMD1-EGFP with CD4-PS1TMD4-myc. CD4-Pen2TMD1-
EGFP (Pen2TMD1) and CD4-PS1TMD4-myc (PS1TMD4) were expressed
separately or together in Cos-7 cells. A) Transfected Cos-7 cells were lysed
using STEN lysis buffer and Western blot analysis was performed with
anti-CD4 and anti-βActin antibodies. B) Transfected cells were stained
for intracellular myc epitope and either for surface CD4 or for total CD4.
Cells were measured by FACS using appropriate gates for the respective
subpopulation (PE+, GFP+ or PE+GFP+) as described in figure 3.24.
The geometric mean of the fluorescence intensities was determined and
the ratios of surface CD4 to total CD4 were calculated for the respective
subpopulations. The error bars depict of n=4 experiments.
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3.4.3 Overexpression of PS1-TMD4 interferes with γ-secre-
tase assembly
As described before, it was initially speculated whether the overexpression of
the Pen2-TMD1 could interfere with the γ-secretase assembly. In work from our
lab and in the course of this work an interference of CD4-Pen2TMD1 expression and
γ-secretase maturation and activity was disproved (data not shown).
In a similar approach it was tested if the isolated overexpression of PS1-TMD4 in-
terfered with γ-secretase assembly. To this end, CD4-PS1TMD4 was stably expressed
in HEK-293 cells. The processing of transiently transfected Notch∆E-EGFP (pro-
vided by Kerstin Hu¨nniger) to Notch intracellular domain (NICD)-EGFP was used
to assess γ-secretase activity. It was shown before that Notch∆E was an immediate
substrate for γ-secretase (Schroeter et al., 1998). The cleavage product NICD-EGFP
was nicely detectable with a neoepitopic antibody against the NICD N-terminus. As
an additional control HEK-293 cells stably expressing an shRNA against Pen2 were
used.
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Figure 3.26: Stable overexpression of PS1-TMD4 interfered with γ-secretase assembly.
HEK-293 wt cells or HEK-293 stably expressing an shRNA against Pen2
or HEK-293 cells stably expressing CD4-PS1TMD4 were transiently trans-
fected with Notch∆E-EGFP (N∆E-EGFP). Cells were lysed 24 h later,
subjected to Western blotting and probed with antibodies against the indi-
cated proteins. The triangle marks the γ-secretase substrate Notch∆E-
EGFP and the star the cleavage product Notch intracellular domain
(NICD)-EGFP. Note that the anti-NICD antibody is neoepitopic, thus only
cleaved Notch∆E-EGFP is detected.
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As expected, HEK-293 cells with a stable knock down of Pen2 lacked mature
Nct, since the assembly and trafficking of γ-secretase was impaired by the lack
of the rate-limiting subunit Pen2 (Steiner et al., 2002; Prokop et al., 2004). The
reduced amount of mature γ-secretase resulted in a strong decrease in Notch∆E-
EGFP cleavage as demonstrated by the reduced NICD-EGFP levels (figure 3.26B,
lane 3). HEK-293 cells stably expressing CD4-PS1TMD4 displayed a comparable
reduction of mature Nct, although Pen2 levels remained unchanged. Likewise, the
reduced levels of mature γ-secretase resulted in a decreased processing of Notch∆E-
EGFP to NICD-EGFP (figure 3.26B, lane 4).
To confirm these results, we analysed the localisation of Notch∆E and its cleavage
product via the fused EGFP moiety. To this end, HEK-293 cells, HEK-293 cells
stably expressing a Pen2-shRNA and HEK-293 cells stably expressing CD4-PS1TMD4
were transiently transfected with Notch∆E-EGFP. Subsequently, cells were fixed,
stained with an anti-CD4 antibody and DAPI and subjected to immunofluorescence
microscopy. Confocal-like optical sections through the nuclei were taken using an
apotome slider module. As described by Schroeter et al., 1998, NICD contained
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Figure 3.27: Stable overexpression of PS1-TMD4 inhibited the cleavage of the γ-
secretase substrate Notch∆E. HEK-293 wt cells or HEK-293 stably ex-
pressing an shRNA against Pen2 or HEK-293 cells stably expressing
CD4-PS1TMD4 were grown on cover slips and transiently transfected with
Notch∆E-EGFP. Subsequently, cells were fixed, stained with an anti-
CD4 antibody and DAPI and subjected to immunofluorescence microscopy.
Confocal-like optical sections were taken using an apotome slider module.
Scalebar 10 µm. Arrowheads, nuclear localisation; Arrows, extra-nuclear
localisation (PM and secretory pathway).
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several nuclear localisation signals. Thus, NICD-EGFP accumulated in the nucleus
of HEK-293 cells after the cleavage of Notch∆E-EGFP by γ-secretase (figure 3.27,
left column). In HEK-293 cells stably expressing a Pen2-shRNA and HEK-293 cells
stably expressing CD4-PS1TMD4 NICD-EGFP was localised to the extra-nuclear
space. Since these cells lacked γ-secretase activity, NICD-EGFP stayed attached to
the membrane in its precursor form Notch∆E-EGFP. The lack of plasma membrane
staining and the strong perinuclear staining resulted from the accumulation of the
transiently overexpressed Notch∆E-EGFP in the ER and Golgi apparatus.
In summary, these results confirmed and extended the findings by Watanabe
et al., 2005, who demonstrated that the binding to CD4-PS1TMD4 stabilised free
Pen2. Moreover, overexpressed CD4-PS1TMD4 acted dominant-negative on γ-secre-
tase assembly, most probably by sequestering unassembled Pen2.
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It was the aim of this work to provide evidence for the quality control hypothesis
for γ-secretase assembly proposed by Kaether et al., 2004. This hypothesis suggests
that all unassembled γ-secretase subunits and assembly intermediates are retained
in the ER by specific ER retention signals. If the complex is properly assembled
these signals are inactivated and thus complex export from the ER to the sites of
γ-secretase activity is permitted. By employing such a quality control system the
cell can assure that nonfunctional or even dysfunctional complexes do not interfere
with normal cellular processes.
4.1 TMD-based ER retention signals are found in dif-
ferent γ-secretase subunits
It has been shown that γ-secretase assembles in the early compartments of the
secretory pathway (Kim et al., 2004; Capell et al., 2005). Although, it was proposed
that ER retention signals on unassembled subunits must exist (Kaether et al., 2004),
at the beginning of this work only one ER retention signal had been identified on all
subunits. This signal is located in the C-terminus of PS1, consists of a stretch of 22
amino acids (ALPALPISITFGLVFYFATDYL)(Kaether et al., 2004) and does not
resemble other known ER retention signals. It is highly conserved between species
(Tomita et al., 2001) and at least partially contributes to the ninth TMD of PS1
(Kaether et al., 2004; Spasic et al., 2006).
The hypothesis by Kaether et al., 2004 already implies the presence of ER re-
tention signals on every single γ-secretase subunit. Otherwise, only some subunits
would be retained in the ER while others proceed to later compartments of the
secretory pathway. The resulting spatial separation would obviate a proper com-
plex assembly. Thus, the first step in this work was the identification of further ER
retention signals in γ-secretase subunits.
4.1.1 The Pen2-TMD1 contains an ER retention signal
Data from others (Bergman et al., 2004a) and from our lab already suggested the
presence of an ER retention signal in Pen2. The application of CD4 as a reporter
for ER retention signals had been well established and a broad spectrum of meth-
ods is at hand to analyse the subcellular localisation of CD4 (Nilsson et al., 1989;
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Zerangue et al., 1999; Kaether et al., 2004). By applying this reporter protein the
ER retention signal in Pen2 was narrowed down to the TMD1 while the presence of
further retention signals in other parts of the protein was disproved (Kaether et al.,
2007).
To obtain ER retention of CD4-Pen2TMD1 the Pen2-TMD1 and the three ad-
jacent cytoplasmic residues (REA) had to be present (figure 3.1A). Individually,
neither the Pen2-TMD1 nor the REA sequence were sufficient to confer ER reten-
tion to CD4. At present, no explanation for the necessity of the three residues exists.
Eventually, they are needed to delimit the TMD and thereby facilitate the correct
insertion of the TMD into the membrane. The relevance of the flanking amino acids
for TMD-based ER retention signals was also described by others. Spasic et al.,
2007 described an ER retention signal in the Nct-TMD. To confer ER retention to
their reporter protein telencephalin, 10 adjacent lumenal amino acids from Nct have
to be exchanged together with the Nct-TMD.
In contrast to cytoplasmic ER retention signals no consensus sequence exists for
TMD-based signals. In literature polar or even charged residues in the context of
a hydrophobic TMD can act as an ER retention signal (Bonifacino et al., 1990a;
Letourneur and Cosson, 1998; Sato et al., 2003). In the Pen2-TMD1 mutagenesis
of a single asparagine at position 16 of the TMD to leucine results in the partial
surface transport of CD4-Pen2TMD1 (Johanna Scheuermann, published in Kaether
et al., 2007). This demonstrates that the retention signal in Pen2 follows the de-
scribed pattern for other TMD-based retention signals. The signals described by
Bonifacino et al., 1990a and Letourneur et al., 1995 not only target the bearing
proteins to the ER but also for ERAD and unassembled Pen2 is targeted for ERAD
as well (Bergman et al., 2004a). Thus, it was tested if the retention signal in the
Pen2-TMD1 is simultaneously responsible for the ERAD targeting and degradation
of Pen2. Our results suggest the opposite. In case of Pen2 the presence of the
polar asparagine stabilises the protein, clearly indicating that other mechanisms are
involved. The observed destabilisation of Pen2 after mutagenesis of the asparagine
was even more pronounced when the adjacent residues or the entire half of the
TMD were mutated. These findings can be easily explained by the altered traffick-
ing of the Pen2 mutants. In work from our lab is was shown that the trafficking of
Pen2N/L to the cell surface is increased (Christoph Kaether, published in Kaether
et al., 2007, figure S2), most likely due to the reduced binding to the retention fac-
tor Rer1 (see section 4.2 and figure 3.14). The altered trafficking might result in
lysosomal degradation of the Pen2 mutants. Similarly, lysosomal degradation was
observed for the α-subunit of the nicotinic acetylcholine receptor (nAChR) which is
released from the ER after Rer1 knockdown (Christina Valkova, unpublished data).
Furthermore, ∆rer1 yeast strains show vacuolar degradation of Rer1 substrates that
are retained in the ER of wildtype strains (Sato et al., 2003). However, to really
prove this hypothesis, the experiment has to be repeated either in the presence of
inhibitors of lysosomal protein degradation (e.g. NH4Cl) or after Rer1 knockdown.
The latter should result in a decreased stability of wildtype Pen2 (due to a lack of
retention) whereas treatment with NH4Cl should stabilise the Pen2 mutants. As an
alternative explanation for the observed instability of the Pen2 mutants, it could be
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speculated that the asparagine is needed for the stabilisation of other polar residues
in the Pen2-TMD2. The Pen2-TMD2 contains a serine and a glutamine which might
destabilise Pen2 in the absence of the opposing asparagine in the Pen2-TMD1. As
a result the destabilised Pen2 mutants are degraded by ERAD. This hypothesis
could be examined by the use of Brefeldin A (BFA) or inhibitors of the proteasome
(e.g. MG-132) in the same experimental setup. BFA blocks the transport from the
ER to the Golgi and thus would allow ER-associated degradation for all GFP-Pen2
variants without an overlaying trafficking effect. On the other hand, MG-132 blocks
proteasomal degradation which is utilised by ERAD.
Similar experiments on the Pen2 stability were performed by Bergman et al.,
2004a. In comparison with their results it can be noticed that the observed halflife
of Pen2 is much lower in their study. This discrepancy is most likely due to the
fused EGFP moiety used here, which forms a very stable structure and attenuates
protein ubiquitinylation and thus increases the halflife of Pen2 (Baens et al., 2006).
4.1.2 A WNF motif is part of an ER retention signal in the
PS1-TMD4
As aforementioned, the presence of polar amino acids is the only loose consensus
for TMD-based ER retention signals found so far. Interestingly, an asparagine in the
PS1-TMD4 was shown to be important in a totally different context. This asparagine
is part of the binding site for Pen2 in the PS1-TMD4 (Kim and Sisodia, 2005a;
Watanabe et al., 2005). It was tested in the present work whether this asparagine
is also part of an ER retention signal or not. By applying the same approaches as
for the signal in the Pen2-TMD1 it was shown that the PS1-TMD4 indeed contains
an ER retention signal. Moreover, the PS1-TMD4 not only confers ER retention
to a CD4 reporter protein but also to Tac. Tac (IL-2 receptor α subunit) has been
extensively used to study ER retention signals in the past (Bonifacino et al., 1990b;
Letourneur et al., 1995; Wang et al., 2002).
By mutating the polar asparagine and the two flanking residues to alanine
(WNFAAA mutation, CD4-PS1TMD4mut) surface transport of the CD4 reporter
is partially restored. For CD4-PS1TMD4mut twofold more CD4 reporter protein is
transported to the plasma membrane in comparison to CD4-PS1TMD4. Although
this increase is statistically significant, it does not represent a complete loss of re-
tention as can be seen in comparison to wildtype CD4. For wildtype CD4, which
represents the upper limit of the assay scale and the complete absence of ER re-
tention, 53.8 % of the reporter protein is at the cell surface. This finding can be
explained by the rapid turnover of the protein. In contrast, inferring from the deg-
lycosylation assay and the FACS analysis more than 50 % of the retention capacity
is still intact in the mutated PS1-TMD4. Thus other residues in the PS1-TMD4
contribute to the ER retention signal.
To get an idea about the other involved residues, the PS1-TMD4 is compared
with the TMD of the yeast protein Sec71p. The ER retention signal in the TMD
of Sec71p was intensively studied and two critical polar residues (Tyr, Ser) were
identified by mutagenesis (Sato et al., 2003). Individual mutation of either residue
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H. sapiens PS1 N V A V D Y I T V A L L I W N F G V V G M I S I
M. musculus PS1 N V A V D Y V T V A L L I W N F G V V G M I A I
R. norvegicus PS1 N V A V D Y I T V A L L I W N F G V V G M I A I
G. gallus PS1 N V A M D Y I T V A L I I W N F G V V G M I C I
X. laevis PSalpha N V A V D Y I T L A L L I W N F G V V G M I C I
D. rerio PS1 N V A M D Y F T L A L I I W N F G V V G M I C I
H. sapiens PS2 N V A M D Y P T L L L T V W N F G A V G M V C I
M. musculus PS2 N V A M D Y P T L F L A V W N F G A V G M V C I
R. norvegicus PS2 N V A M D Y P T L F L A V W N F G A V G M V C I
G. gallus PS2 N V A M D Y P T V I L I I W N F G A V G M I R I
X. laevis PSbeta N I A M D Y P T L F M V I W N F G A V G M I C I
D. rerio PS2 N V A M D Y P T L L M I I W N F G V V G M I C I
D. melanogaster Psn N I P M D Y P T A L L I M W N F G V V G M M S I
E. histolytica PS N W P V D W I S F A F L L F N F G V L G V I S I
D. discoideum PS1 N L G L D Y V T F V I V V W N F S V G G I V C I
D. discoideum PS2 N L P L D Y I T F A F L I F N F T V C G I I G V
T. brucei PS Q I P Y D F I T M F L V L W N T G V V G L V S I
C. elegans SEL-12 D V S P S A L L V L F G L G N Y G V L G M M C I
C. elegans HOP-1 S I P V S V P T F F F L I L Q F G G L G I T C L
A. thaliana PSI S I P V D S I T C F I L L F N F T I L G T L S V
A. thaliana PSII R F P I D S I T F L I L L F N F S V V G V F A V
Consensus N D Y T W N F G V G I
a a a * * *
Figure 4.1: TMD-based ER retention signals can be based on several polar residues
with a defined interspace. A) Comparison between the PS1-TMD4 and the
Sec71p-TMD in a simplified helical wheel projection. The projection as-
sumes 3.5 amino acids per turn and the amino acids are labelled from a to
g, which corresponds to two turns of the helix. Accordingly, for every sev-
enth amino acid the same relative position is reached again. The last three
(most C-terminal) amino acids of the helices are not shown to simplify the
picture. The projection covers 3Ö7 amino acids resulting in three rings in
the projection. Polar or charged residues are coloured in blue and residues
that have been mutated in this study (PS1-TMD4) or in Sato et al., 2003
(Sec71p-TMD) are marked with an asterisk. B) Alignment of PS-TMD4.
Darker blue depicts a higher degree of conservation. The small a indicates
residues that are located to the a-position in the helical wheel projection of
PS1-TMD4. The WNF motif that has been mutated in this study is un-
derlined. The small asterisks indicate residues that were found mutated in
cases of FAD.
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to leucine in the context of a reporter protein led only to partial release of the
reporter from the ER. In a helical wheel projection of Sec71p both residues are
found at the same side of the α-helix of the TMD. Together with another serine at
the same side a polar interface is formed rendering the α-helix of the Sec71p-TMD
amphipathic (figure 4.1A, right helix, 3 o’clock). To permit ER exit, the polar
interface has to be mutated completely . Similarly, the asparagine in the WNF
motif of the PS1-TMD4 is part of a polar interface comprised of two asparagines, a
threonine and an aspartate (figure 4.1A, left helix, 11 o’clock; figure 4.3). This polar
interface of the helix is highly conserved over all species and even in cases where
a residue is not conserved another polar residue is present instead (figure 4.1B).
Thus, it is likely that these other polar residues of the PS1-TMD4 contribute to
ER retention and that mutation of these residues to non-polar amino acids allows
ER export of the CD4 reporter. A very similar polar interface comprising an ER
retention signal was described for the Nct-TMD (Spasic et al., 2007). The polar
interface of the TMD4 is conserved between PS1 and PS2 (figure 4.1B). Hence, it is
likely that the PS2-TMD4 also contains an ER retention signal, although this has
not yet been tested explicitly.
The presence of two ER retention signals in the PS1-TMD4 (WNF) and the
PS1-TMD9 (PALP) raises the question of the relevance of the individual signals.
To address this question both signals were mutated individually or together in PS1-
EGFP (PE). In contrast to the findings by Kaether et al., 2004 no ER-located PE
was visible in HeLa Kyoto cells (figure 3.12). This discrepancy can be explained
by the different cell line used here (HeLa Kyoto instead of HEK-293) and/or the
lower expression level of PE in the HeLa Kyoto cells. The low expression prevents
accumulation of unassembled PE in the ER, since all newly synthesised PE is imme-
diately bound by Nct/Aph-1 heterodimers and after the binding of Pen2 a complete
γ-secretase complex is formed. Subsequently this complex is transported to the
plasma membrane, resulting in the absence of ER staining in the steady-state. Al-
though the absence of unassembled PE was not formally demonstrated here, other
observations support this interpretation. It was shown by several groups, that ex-
ogenous expression of functional PS1 variants results in a reduced expression of
endogenous PS1 and PS2 (reviewed in De Strooper, 2003). This phenomenon pre-
vents the competition of the exogenously expressed PE species with endogenous
PS1/PS2 for the binding to the Nct/Aph-1 heterodimer and allows the rapid incor-
poration of the exogenously expressed PE variants. Hence, the described reduction
of ER staining for PE−PALP (Kaether et al., 2004) could not be observed, because
already for the stably expressed PE no ER staining was visible.
Interestingly, mutation of the second ER retention motif in the PS1-TMD4
(PE−WNF ) resulted in the ER localisation, a finding which was surprising at first
glance. This observation can be explained by the altered assembly status of
PE−WNF , because the WNF motif also serves as a binding site for Pen2. In contrast
to PE or PE−PALP , PE−WNF does not assemble into complete γ-secretase complexes
and accumulates in trimeric assembly intermediates with Nct and Aph-1. In these
assembly intermediates additional ER retention signals are not inactivated and the
heterotrimer of Aph-1, Nct and PE−WNF stays in the ER. In contrast, PE and
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PE−PALP are incorporated into a complete γ-secretase complex and ER retention
signals are inactivated, resulting in the observed plasma membrane localisation of
PE and PE−PALP complexes. In summary, it becomes apparent that the compari-
son of PE−PALP and PE−WNF is impossible due to their different assembly status.
Nevertheless, it is interesting that the double mutant PE−PALP−WNF was located to
the ER. This implies that further ER retention signals contribute to the localisation
of the trimeric assembly intermediate.
These signals are not necessarily limited to PE but could also be located in the
other subunits Aph-1 and Nct. For instance, the folding status of the highly glyco-
sylated Nct ectodomain could serve as an additional assembly sensor and ER reten-
tion signal. The folding of the Nct ectodomain into a trypsin-resistant conformation
probably occurs in the ER, because it does not require the extensive glycosylation
obtained in the later Golgi. This is demonstrated by an artificially ER-localised
Nct that becomes trypsin-resistent after the complete assembly of an ER-localised
γ-secretase complex (Capell et al., 2005). The unfolded Nct ectodomain could be
bound by chaperones like calnexin and calreticulin in the ER until it undergoes a
conformational switch after the correct γ-secretase assembly. In this way, the Nct
ectodomain could also serve as an assembly sensor, explaining why the Nct/Aph-
1/PE−PALP−WNF heterotrimer was located in the ER. However, additional signals
could be located in any of the three subunits.
To explicitly test if there are other ER retention signals in PS1 but the described
ones in the TMD4 and the TMD9, the last seven amino acids were deleted in all PE
variants. The resulting PE∆7 variants are not bound to assembly intermediates since
the binding to Nct is obviated (Kaether et al., 2004). All PE∆7 variants were located
in the ER in stably expressing HeLa Kyoto cells, which indicates that additional ER
retention signals have to exist within PS1. However, none of the classical RXR-type
or KKXX-type ER retention signals can be found in the cytoplasmic domains of PS1.
TMD-based or atypical cytoplasmic retention signals could exist that are responsible
for the ER localisation of the PE∆7 variants. On the other hand, it is possible that
the ER export of PS1 depends on the presence of ER export signals which might
be provided by other subunits or which become exposed after the proper complex
assembly. The presence of more than two ER retention signals in PS1 does not
necessarily render the described signals insignificant. Rather, it is likely that each
and every signal is involved in probing a particular aspect of the assembly of γ-
secretase. Following the hypothesis proposed by Kaether et al., 2004, every signal
could for instance sense one subunit-subunit interaction (see section 4.3).
The observation that all PE∆7 variants were located in the ER is in contrast to
the findings by Kaether et al., 2004, who described that unassembled PE−PALP was
released from the ER in HEK-293 cells. Their results imply that the signal in the
PS1-TMD9 (PALP) is the most important and dominating signal in PS1. This is
disproven by the ER localisation of the PE∆7−PALP observed in the present study.
Just like for Pen2, the question raises if the polar residues in the ER retention
signal of the PS1-TMD4 are also a degradation signal. Additionally, the PS1-TMD9
also contains polar residues that contribute to ER retention (Kaether et al., 2004).
Both signals described for PS1 could provide an easy explanation for the observed
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instability of non complex-associated presenilin (Edbauer et al., 2002; Takasugi et al.,
2003), but this has to be tested experimentally.
4.2 Similar TMD-based ER retention signals are re-
cognised by different mechanisms
Little knowledge exists on how TMD-based ER retention is accomplished. The
only described protein that recognises TMD-based signals is the yeast protein Rer1p
which is highly conserved from yeast to human (Sato et al., 1995; Boehm et al.,
1997; Massaad et al., 1999). It was tested if mammalian Rer1 accomplishes the ER
localisation of PS1 and Pen2, because both contain potential Rer1-dependent signals.
By applying CD4 reporter proteins it was shown that only the signal in the Pen2-
TMD1 depends on Rer1 and thus Pen2 is the first identified substrate of mammalian
Rer1. Knockdown of Rer1 using siRNA caused an increased surface localisation
of CD4-Pen2TMD1, although a complete release (meaning similar localisation like
wildtype CD4) was not observed. The observed knockdown of Rer1 on the protein
level was not complete and the residual Rer1 could be enough to ensure a partial
ER retention of CD4-Pen2TMD1. Moreover, it was observed in yeast that reporter
proteins used to study Rer1p-dependent ER localisation, are partially ER retained
even in a ∆rer1 yeast strain (Sato et al., 1996). It is possible that substrates of
Rer1 are retained in the ER also by other mechanisms besides Rer1-dependent ER
localisation, for instance by exclusion from ER exit sites (Barlowe, 2000).
In yeast it was shown that the Rer1p-dependent ER retention of reporter proteins
is saturable. High overexpression of the reporter causes ER release which can be
rescued by additional overexpression of Rer1p (Sato et al., 1997). Similar effects
have been observed in this study and the ER retention capacity seems to be cell
type specific. Transient overexpression of CD4-Pen2TMD1 in HEK-293 cells resulted
in a prominent surface staining (data not shown), whereas the stable, more modest
expression resulted in ER retention. On the other hand, transiently overexpressed
CD4-Pen2TMD1 was well retained in the ER in Cos-7 cells and to a lesser extent in
HeLa Kyoto cells (data not shown). In summary, the mammalian Rer1-dependent
ER retention of Pen2 follows the mechanisms described for yeast.
The interaction between Rer1 and unassembled Pen2 was demonstrated by co-
immunoprecipitation with stably overexpressed proteins. The absence of other γ-
secretase subunits but Pen2 in the co-immunoprecipitation under conditions that
leave the γ-secretase intact pinpoint the specific binding of Rer1 to the unassembled
Pen2. The amount of co-immunoprecipitating Pen2 was very low, most likely due to
low levels of unassembled Pen2. These low levels result from the high instability of
the unassembled protein (Bergman et al., 2004a) and from the rate limiting character
of the Pen2 incorporation into the γ-secretase (Takasugi et al., 2003; Prokop et al.,
2004). Hence, unassembled Pen2 is either rapidly degraded or incorporated. Ad-
ditionally, the amount of co-immunoprecipitating Pen2 is reduced by the transient
character of the interaction with Rer1. Rer1 is a retrieval factor for Pen2 and only a
minor amount of the unassembled Pen2 is in the process of retrieval from the ERGIC
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or cis-Golgi. For this reasons, the co-immunoprecipitation of endogenous Pen2 is
impeded since the levels of endogenous, unassembled Pen2 are even lower. Further
evidence for the relevance of the Rer1-dependent ER retention of Pen2 results from
HEK-293 cell stably overexpressing Rer1-V5. In these cells slightly elevated levels of
Pen2 were observed (Christoph Kaether, published in Kaether et al., 2007, figure 4).
The increased binding of Rer1 to Pen2 in these cells might result in the protection
of Pen2 against degradation in lysosomes and/or by ERAD.
In parallel to the present study, a report by Spasic et al., 2007 failed to show
the binding of Pen2 to Rer1. However, this contradictory finding might emerge
from experimental differences. The use of chemical cross-linking by Spasic et al.,
2007 might be a bad choice since domains that could be cross-linked between Rer1
and Pen2 are very small. Rer1 has cytoplasmic domains but virtually no lumenal
domains. In contrast, the cytoplasmic domain of Pen2 is relatively small and poor
of lysines.
Interestingly, the signal in the PS1-TMD4 does not depend on Rer1, although
it contains an asparagine in a similar position. The question raises what makes
the difference between the PS1-TMD4 and the Pen2-TMD1. Both TMDs contain
an ER retention signal based on polar residues and both TMDs are composed of
amphipathic α-helices, because polar residues form a non-hydrophobic interface at
one side of the helix (figure 4.3). From work in our lab and by others two other
proteins are known that carry TMD-based ER retention signals but do not depend
on Rer1. The TCRα chain contains an ER retention/degradation signal based on
charged residues (Bonifacino et al., 1990a) which does not depend on Rer1 (Slavomir
Kacmar, unpublished data). On the other hand, the yeast protein Ufe1p possesses a
TMD-based ER retention signal composed of a non-hydrophobic interface in the α-
helix. Although this signal matches the signals in typical Rer1 substrates it does not
depend on Rer1p (Rayner and Pelham, 1997). To allow a clearer view on differences
that could determine the Rer1-dependency, the known substrate TMDs of Rer1 were
compared with the TMDs of Ufe1p, TCRα and the PS1-TMD4 (table 4.1). Despite
the heterogeneity of the amino acids that are important for the Rer1-mediated ER
localisation it is remarkable that none of the TMDs interacting with Rer1 contains
charged amino acids. In contrast, the TMDs of Ufe1p, TCRα and the PS1-TMD4
contain one or more charged residues. Eventually, the presence of charges within
the hydrophobic context of a TMD interferes with the binding to Rer1 and instead
other mechanisms are used for such signals.
To further substantiate this hypothesis the TMDs of Rer1 were examined, be-
cause they have to accomplish the interaction with substrate proteins that carry
TMD-based retention signals. Especially the TMD4 of Rer1 exhibits a high degree
of conservation from yeast to human (figure 4.2). This indicates that the Rer1-
TMD4 could be of special importance for the interaction with Rer1 substrates.
Furthermore, mutation of the tyrosine in the TMD4 to leucine resulted in a loss of
interaction with Sec12p and the ER retention of Sec12p was abrogated, although the
same mutation did not affect the interaction with Sec71p (Sato et al., 2003)(figure
4.2, asterisk). It is known from the TCRα subunit that an interaction with amino
acids of oppositional charge lead to stabilisation and ER release of TCRα (Bonifa-
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Table 4.1: TMDs that are recognised by Rer1 do not contain charged amino acids. The
upper part of the table shows all TMDs that have been described to be sub-
strates of Rer1. TMDs in the lower part are localised to the ER in a Rer1-
independent manner. Residues that have been described to be critical for ER
retention are underlined and charged amino acids have a yellow background.
protein TMD sequence reference
Sec12p LSFQLIYSLLVILIFNTFF
Sato et al., 1995
Sato et al., 1996
Sec71p ISVYTPLIYVFILVVSLVMFASSY
Sato et al., 1997
Sato et al., 2003
Fet3p IIAMTFSCFAGILGIITIAIYGMM Sato et al., 2004
Mns1p WPVYYIAAIIAVITAISIGV
Massaad et al., 1999
Massaad and Herscovics, 2001
Sed4p YGLQIAGALVVLLLLVFNLFF Sato et al., 1996
Gas1p VVFTSIISLSIAAGVGFA Letourneur and Cosson, 1998
Nct LITLTVGFGILIFSLIVTYCI Spasic et al., 2007
Pen2-TMD1 YYLGGFAFLPFLWLVNIFWFF this study
Ufe1p K LTTYGAIIMGVFILFL D Rayner and Pelham, 1997
PS1-TMD4 NVAV D YITVALLIWNFGVVGMISI this study
TCRα NLSVMGL R ILLL K VAGFNLLMTL Bonifacino et al., 1990a
| |
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Figure 4.2: The TMD4 of Rer1 is highly conserved from yeast to human. Alignment
of the four TMDs of yeast and human Rer1. The TMD regions are in
accordance with Boehm et al., 1994. The asterisk depicts a tyrosine that is
critical for the retention of Sec12p but not for the retention of Sec71p (Sato
et al., 2003).
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cino et al., 1990a). It is likely that charged residues would be needed in the TMDs
of Rer1 to stabilise an interaction with charged, TMD-based ER retention signals.
However, the only conserved charged residue is an arginine in the less conserved
TMD1.
Taken together, the retention signals in the Pen2-TMD1 and the PS1-TMD4
belong to two different classes of signals. On the one hand, retention signals in TMDs
that contain charged residues like the ones in the PS1-TMD4 or the TCRα-TMD.
These signals might also be involved in targeting the protein to ERAD, depending
on the relative position of the charged residue within the TMD (Bonifacino et al.,
1991). These signals cannot be bound by Rer1 since Rer1 cannot stabilise the
energetically unfavourable charge in the hydrophobic membrane. On the other hand,
there are signals composed of polar residues like the one in the Pen2-TMD1. Those
signals can be bound by Rer1 via interactions with polar residues in the TMDs of
Rer1. However, this hypothesis is of course speculative at present and needs to be
substantiated by experimental results.
4.3 Interaction of TMDs causes masking of ER reten-
tion signals
A quality control machinery that probes the assembly status of protein com-
plexes via ER retention signals has to include mechanisms which finally permit
the ER export of a correctly assembled complex. Accordingly, these retention sig-
nals have to be inactivated after the complex is properly assembled for instance by
phosphorylation (Scott et al., 2001), sterical masking (Margeta-Mitrovic et al., 2000;
Horak et al., 2008), charge neutralisation (Bonifacino et al., 1990a; Letourneur et al.,
1995) or binding of masking proteins (Standley et al., 2000; Yuan et al., 2003)(see
also section 1.3.3). Both the PS1-TMD4 and the Pen2-TMD1 were implicated in
the interaction between PS1 and Pen2 (Kim and Sisodia, 2005a,b; Watanabe et al.,
2005). Thus, it is an intriguing possibility that the protein-protein interaction be-
tween the two TMDs results in a masking of the respective ER retention signals.
This hypothesis was tested by co-expression of the isolated TMDs in the context
of different reporter proteins. Indeed, a partial ER export was observed in cells
co-expressing both reporter proteins. Since the Pen2-TMD1 and the PS1-TMD4
are retained in the ER by different mechanisms the observed effect is not due to a
competition for limiting retention factors (see section 4.2). However, the proportion
of released reporter proteins was rather small as can be judged from immunofluo-
rescence and as was measured by FACS analysis. The reason for this could be the
weakness of the interaction between the TMDs in the reporter proteins. In the full-
length proteins the binding of Pen2 to PS1 is presumably stabilised by additional
interactions between other parts of the subunits. A candidate region for such an
interaction could be the C-terminus of Pen2, which is involved in the stabilisation
of the PS1 NTF/CTF heterodimer (Prokop et al., 2005; Kim and Sisodia, 2005b).
The weak interaction between the isolated TMDs decreases the probability that the
formed heterodimer of the reporter proteins stays tied together until it has passed
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early Golgi compartments. Since later Golgi compartments do not contain further
quality control checkpoints, both reporter proteins can proceed to the PM even if
they fall apart again after having passed the cis-Golgi (Mezzacasa and Helenius,
2002).
For the PS1-TMD4 the interaction motif (WNF) is also part of the ER retention
signal and thus the WNF sequence is bifunctional. However, for the Pen2-TMD1
the situation is less clear. Kim and Sisodia, 2005b provided evidence that the prox-
imal two-thirds of the Pen2-TMD1 contain a binding site for PS1. In their work,
transiently overexpressed Pen2 co-immunoprecipitated with PS1 even if the distal
one-third of the TMD1 was replaced with a TMD from an unrelated protein. This
construct lacks the asparagine which is important for the proper ER retention of
Pen2. In contrast, work from our lab suggests that the distal part of the Pen2-
TMD1 is of high relevance. Replacement of the nine most distal amino acids of the
Pen2-TMD1 with the corresponding sequence from CD4 (GFP-Pen2CD4) resulted
in an increased instability of this GFP-Pen2 mutant (figure 3.6). Moreover, stably
expressed GFP-Pen2CD4 failed to rescue γ-secretase assembly and function in Pen2
knockdown cells (Johanna Scheuermann, published in Fassler et al., 2009, figure 3).
Both observations can be explained with an altered trafficking of GFP-Pen2CD4 that
leads to lysosomal degradation (see section 4.1). In the study of Kim and Sisodia,
2005b, the transient overexpression of the chimera that has one-third of the distal
Pen2-TMD1 replaced might conceal this trafficking phenotype due to high expres-
sion levels. The overexpression of the Pen2 chimera results in an ER accumulation
and thus allows binding to PS1, although both proteins would be spatially separated
when expressed at lower levels. On the other hand, it is possible that the incapa-
bility of GFP-Pen2CD4 to rescue the Pen2 knockdown is indeed due to an impaired
binding to PS1. The proximal two-thirds of the Pen2-TMD1 could be needed for
the correct spatial orientation of the distal one-third, which contains the asparagine.
Additional experiments from our lab confirmed the binding of the Pen2-TMD1 as a
whole to the PS1-TMD4, although this has not been dissected down to single amino
acids or a motifs in the Pen2-TMD1 (Sebastian Klare, published in Fassler et al.,
2009, figure 3).
In summary, it was shown here for the first time how masking of TMD-based
ER retention signals is achieved. Both, the PS1-TMD4 and the Pen2-TMD1 are
bifunctional, since they contribute to the protein-protein interaction between PS1
and Pen2 and contain ER retention signals. This bifunctionality of TMDs in different
complex subunits provides an effective way for the ER quality control to probe the
assembly status of multimeric complexes. The binding of Pen2 to PS1 masks the ER
retention signals in the PS1-TMD4 and the Pen2-TMD1 and thus marks this part of
the complex as assembled. As assumed by Sato et al., 2001, the higher affinity of the
TMDs for the correct binding partner could ensure that components of the quality
control mechanism do not interfere with complex assembly by competition. For the
PS1-TMD4 the bifunctionality is provided by the WNF motif, which serves as a
binding site for Pen2 and as an ER retention signal. The situation is less clear for
the Pen2-TMD1. It was shown by our laboratory that the asparagine contributes to
ER retention, whereas the localisation of the binding site for PS1 in the Pen2-TMD1
68
Discussion
is still controversial.
The interaction between the PS1-TMD4 and the Pen2-TMD1 is schematised
in figure 4.3. It is likely that the polar or charged residues in both TMDs face
each other, because the exposure of hydrophilic amino acids to the hydrophobic
environment of a membrane is energetically unfavourable. The interaction between
non-hydrophobic amino acids in TMDs was shown before for several proteins (re-
viewed in Moore et al., 2008). However, the detailed interactions between these
amino acids and how they contribute to the specificity of the interaction between
the Pen2-TMD1 and the PS1-TMD4 remains unclear. It could be tried to address
this question with an in silico approach.
In the present study, the findings by Watanabe et al., 2005 were confirmed and
extended. The stable overexpression of the PS1-TMD4 via CD4-PS1TMD4 resulted
in an attenuation of γ-secretase assembly and thus in a decreased activity. The
dominant-negative effect results most likely from a sequestration of Pen2 by the
CD4 reporter protein. This would also explain the normal levels of Pen2 in these
cells, since it was shown by Watanabe et al., 2005 that CD4-PS1TMD4 is sufficient
to protect unassembled Pen2 from degradation. Taking into account our results on
the masking, it could be argued that CD4-PS1TMD4/Pen2 heterodimers should be
transported to the plasma membrane. Indeed, cells stably expressing CD4-PS1TMD4
showed significantly more CD4 at the plasma membrane than cells stably express-
ing CD4-Pen2TMD1 or CD4-RXR. However, no elevated surface localisation could
be observed by immunofluorescence. This might by due to the relatively high over-
expression of CD4-PS1TMD4 in comparison to the much lower levels of endogenous
Pen2. The small fraction of released CD4-PS1TMD4 is concealed by the much big-
ger fraction that does not bind to Pen2 and is accordingly retained in the ER. To
ultimately test this hypothesis, CD4-PS1TMD4 has to be expressed in stable Pen2
knockdown cells which should result in a stronger ER retention of the CD4 reporter
protein.
Since stable overexpression of CD4-PS1TMD4 interferes with γ-secretase assem-
bly, it was analysed whether CD4-Pen2TMD1 has the same effect. Stable overex-
pression of CD4-Pen2TMD1 did not result in a reduction of γ-secretase assembly,
although this finding is a little bit incomprehensible at first glance. In contrast to
CD4-PS1TMD4, CD4-Pen2TMD1 could interfere with the assembly even in two ways.
First and obviously, CD4-Pen2TMD1 could compete with endogenous Pen2 for the
binding to PS1. However, the big ectodomain of CD4 might constrain the binding to
PS1 for sterical reasons, especially under consideration of the almost 20-fold smaller
lumenal domains of Pen2. To address this issue, a CD4-Pen2TMD1 stub construct
was generated, lacking almost the entire ectodomain of CD4. Although this stub
is localised to the ER as expected, no interference with the γ-secretase assembly
was observed in preliminary experiments (data not shown). Secondly, stable, high
level overexpression of CD4-Pen2TMD1 should result in a saturation of the Rer1-
dependent ER retention machinery as it was described in yeast (Sato et al., 1997).
As a consequence, the much lower expressed endogenous Pen2 should be transported
to later Golgi compartments and eventually be degraded in the lysosomes (see sec-
tion 4.1). The resulting spatial separation would then lead to an attenuation of
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Figure 4.3: The amphipathic helices of the PS1-TMD4 and the Pen2-TMD1 could in-
teract via polar residues. A) Simplified helical wheel projection of the Pen2-
TMD1 and the PS1-TMD4. The projection assumes 3.5 amino acids per
turn and the amino acids are labelled from a to g, which corresponds to
two turns of the helix. Accordingly, for every seventh amino acid the same
relative position is reached again. The last three (most C-terminal) amino
acids of PS1 are not shown to simplify the picture. The projection covers
3Ö7 amino acids resulting in three rings in the projection. Polar or charged
residues are coloured in blue and residues that have been mutated in this
study are marked with an asterisk. The polar interfaces of the helices could
contribute to the protein-protein interaction between PS1 and Pen2 via their
polar residues (highlighted in grey). B,C) Three-dimensional structures of
the PS1-TMD4 and Pen2-TMD1 assuming an ideal α-helical structure for
the TMDs. B) provides a side view with the polar interfaces facing each
other. In C) a view onto the polar surfaces of the TMDs is shown. Pictures
in B) and C) were generated with PyMOL (DeLano, 2008)
the γ-secretase assembly. Although this experiment has not yet been performed, it
mimics the situation of a long-time Rer1 knockdown. However, knockdown of Rer1
by siRNA over nine days did not lead to decreased levels of mature Nct, which would
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be indicative of an impaired γ-secretase assembly (Christina Valkova, unpublished
data). In contrast, Spasic et al., 2007 observed a slightly decreased fraction of fully
glycosylated Nct after 72 h of Rer1 knockdown. Although, their results match the
predictions that were made here, their explanation is completely different. In sum-
mary, no convincing explanation can be given why the isolated overexpression of
the Pen2-TMD1 does not interfere with the γ-secretase assembly. Sterical problems
might be the reason for CD4-Pen2TMD1, whereas this should not be the case for
the stub construct. Further experiments with the stub and/or Pen2-TMD1 pep-
tides might resolve this issue. Concerning the effect of an Rer1 knockdown or an
overloading of the Rer1 machinery it is not clear to what extent the localisation
of Pen2 to the ER depends on this mechanism. Experiments with ∆rer1 yeast
strains demonstrated that substrates of Rer1 are localised to the ER by additional
mechanisms besides the Rer1 machinery (Sato et al., 1996). Accordingly, it has to
be analysed to what extent loss of Rer1 affects the ER localisation of Pen2. This
question could be addressed with Rer1−/− MEF cells.
4.4 Conclusions and perspectives
In the present study, evidence was provided that supports the quality control
hypothesis for the γ-secretase assembly which was initially proposed by Kaether
et al., 2004. New ER retention signals were identified in the PS1-TMD4 and the
Pen2-TMD1. Both signals are based on polar residues that are part of a hydrophilic
interface in the hydrophobic environment of a TMD. For the signal in the Pen2-
TMD1 it was shown that it also affects the stability of Pen2, although it is not clear
whether this happens via an interaction with a degradation machinery or via altered
trafficking of Pen2. Furthermore, Pen2 was identified as the first substrate of Rer1-
mediated ER retention in mammalian cells, whereas the signal in the PS1-TMD4 is
Rer1-independent. In this context, first evidence suggests that there could be at least
two different kinds of TMD-based ER retention signals, which are based on different
machineries: TMD-based retention signals that are based on polar residues but lack
charged amino acids are based on Rer1. On the other hand, signal-carrying TMDs
that contain charged residues are Rer1-independent. The mechanism accomplishing
the retention of such signals remains completely unknown.
As the major finding, it was shown that both the Pen2-TMD1 and the PS1-
TMD4 are bifunctional. They confer ER localisation to their carrying proteins and
constitute sites of protein-protein interaction. The bifunctionality of the TMDs
provides a mechanism by which the ER retention signals can be masked in the
properly assembled γ-secretase. Thus, they serve as a sensor for the ER quality
control. The findings of the present work are summarised in the figure 4.4 which
illustrates a model for the quality control of γ-secretase assembly.
For the first time detailed insight was provided into the mechanism that leads
to the masking of TMD-based ER retention signals. Under consideration of the
obtained results one can speculate that the masking of the retention signals in the
Nct-TMD and the PS1-TMD9 results from similar a mechanism. Both domains
are bifunctional as well, since they contain ER retention signals and are involved
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Figure 4.4: Correct assembly of γ-secretase results in the inactivation of ER retention
signals. ER retention signals have been identified in Pen2 (dark blue), PS1
(orange) and Nct (green). The signals in Pen2 and Nct depend on Rer1,
whereas the machinery recognising the signals in PS1 is unknown. The
binding of the Pen2-TMD1 to the PS1-TMD4 masks the signals in the two
TMDs. The binding of the PS1 C-terminus to the Nct-TMD could cause the
masking of the signals in the Nct-TMD and the spatially close PS1-TMD9,
although this is speculative at present. Correct assembly of the γ-secretase
results in the folding of the Nct ectodomain and in the endoproteolytic cleav-
age of PS1 holoprotein to PS1-NTF (red) and PS1-CTF (yellow). The com-
pletely assembled complex lacks open ER retention signals and is transported
to the plasma membrane and/or endosomes.
in protein-protein interaction either directly (Nct-TMD) or via adjacent regions
(PS1-TMD9)(Kaether et al., 2004; Spasic et al., 2007). The binding of the last
amino acids of the PS1 C-terminus to the Nct-TMD could mask the signals in the
Nct-TMD. In parallel, this binding could result in a sterical masking of the closely
neighbouring PS1-TMD9. Moreover, the findings of the present study could be
generalised for the quality control of other multimeric membrane proteins, like cell
surface receptors or ion channels. For instance, a TMD-based ER retention signal
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has been described for the nAChR (Wang et al., 2002) and data from out lab suggest
that this signal depends on Rer1 (Christina Valkova, unpublished data). This signal
could be masked by interactions between the multiplicity of TMDs found in the
α-, β-, δ- and -subunit which finally form the functional nAChR with an α2βδ
stoichiometry.
The present study points to the relevance of the TMDs of γ-secretase for the
proper assembly of the enzyme. Others showed that the TMDs are also of impor-
tance for the activity of γ-secretase. Besides the fact that the catalytically active
residues are located in the TMDs 6 and 7 of presenilin, evidence emerges that the
targeting of TMDs might be a promising approach for pharmacological interven-
tion. It was demonstrated that isolated TMD peptides derived from the γ-secretase
modulator TMP21 can reduce γ-secretase activity (Pardossi-Piquard et al., 2009).
Furthermore, recent findings suggest that some of the known γ-secretase modula-
tors (GSMs, e.g. fenofibrate and flurbiprofen) target a region of the Aβ domain that
is located in the TMD of APP (Kukar et al., 2008). Another option described in
the literature is the usage of computed helical anti-membrane proteins (CHAMPs).
Experimental evidence demonstrated that CHAMPs can be used to disrupt TMD-
based interactions between α- and β-integrins (Yin et al., 2007). Similarly, it is
possible that PS1-TMD4 derived peptides can be used to disrupt the γ-secretase
complex and thereby inhibit γ-secretase activity in pathological situations.
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
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PLASMID DATA SHEET 
 
Name: CD4-TM1-EGFP / pcDNA3.1/Hygro(+) 
Constructed by: Matthias Faßler 
Plasmid: pcDNA3.1/Hygro(+) 
Insert: fusion protein hCD4-TM1 and EGFP 
Cloning sites: BamHI / ApaI 
Resistance: Amp , Hygro 
Diagnostic REN: NdeI (4135, 3516) 
Reference:  
CD4-TM1-EGFP pcDNA3.1/Hygro(+)
7651 bp
Amp(R)
Hygro(R)
CD4
EGFP
Pen2-TM1SV40 pA
BGH pA
BGH reverse primer
CMV forward primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
T7 promoter
f1 origin
pUC origin
ApaI (3049)
BamHI (930)
NotI (2317)
 
Construction: EGFP was amplified using primer EGFP-F NotI GCGGCCGCGATGGTGAGCAAGGGC (introducing 
NotI) and EGFP-R ApaI GGGCCCTTACTTGTACAGCTCGTC (introducing ApaI). CD4-TM1 was amplified using 
primer CD4-F BamHI *alt* GGATCCGCCACCATGAACCGGGGAGTCCC (introducing BamHI and Kozak 
sequence) and CD4-R NotI GCGGCCGCAATGGGGCTACATGT (introducing NotI). PCR products were TOPO TA 
cloned, cut with their respective RENs and then subsequently cloned into pcDNA3.1/Hygro(+) using BamHI, NotI and 
ApaI sites. Transition site: SPIaaaMVSK. The fusion leads to the insertion of 3 alanin (aaa). 
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: CD4-TM4 / pcDNA3.1 Zeo(+) 
Constructed by: Matthias Faßler, Alerie Guzman 
Plasmid: pcDNA3.1 Zeo(+) 
Insert: hCD4 with PS1-TMD4 
Cloning sites: BamHI, XhoI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII (3451 bp, 1749 bp, 1151 bp) 
Reference:  
hCD4-TM4 / pcDNA3.1/Zeo(+)
6351 bp
Amp(R)
Zeo(R)
CD4
PS1-TMD4
SV40 pA
BGH pA
BGH rev erse primer
CMV forw ard primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
EM7 promoter
T7 promoter
f1 origin
pUC origin
Mat Peptide 1
Sig Pept 1
BamHI (4960)
XhoI (1)
 
Construction: CD4-TM4 was generated by a standard deletion/insertion protocol for site directed mutagenesis from 
CD4/pcDNA3.1 Zeo(+). SP CD4-TM4PS 5’-GCACTCCTGATCTGGAATTTTGGTGTGGTGGGAATGATTT 
CCATTAGGTGCCGGCACCGAAGG-3’; ASP CD4-TM4PS 5’-ATTCCAGATCAGGAGTGCAACAGTAATGT 
AGTCCACAGCAACGTTCATTGGCTGCACCGGG-3’ 
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: CD4-TM4mut / pcDNA3.1 Zeo(+) 
Constructed by: Matthias Faßler, Alerie Guzman 
Plasmid: pcDNA3.1 Zeo(+) 
Insert: hCD4 with PS1-TMD4; introduced WNF->AAA mutation 
Cloning sites: BamHI, XhoI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII (3451 bp, 1749 bp, 1151 bp) 
Reference:  
hCD4-TM4mut / pcDNA3.1/Zeo(+)
6351 bp
Amp(R)
Zeo(R)
CD4
PS1-TMD4mut
SV40 pA
BGH pA
BGH rev erse primer
CMV forw ard primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
EM7 promoter
T7 promoter
f1 origin
pUC origin
Mat Peptide 1
Sig Pept 1
BamHI (4960)
XhoI (1)
 
Construction: CD4-TM4mut was obtained using site directed mutagenesis on CD4-TM4 / pcDNA3.1 Zeo(+). SP TM4 
WNF->AAA 5’-ATTACTGTTGCACTCCTGATCGCGGCTGCTGGTGTGGTGGGAATG-3’; ASP TM4 WNF-
>AAA 5’-CATTCCCACCACACCAGCAGCCGCGATCAGGAGTGCAACAGTAAT-3’. 
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: PE Δ7 -PALP -WNF / pcDNA3.1 Zeo(+) 
Constructed by: Matthias Faßler 
Plasmid: pcDNA3.1 Zeo(+) 
Insert: PS1-EGFP Δ7 -PALP with a WNF->AAA mutation in the TMD4 
Cloning sites: EcoRI, XhoI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII + NotI (4011 bp, 1749 bp, 723 bp, 623 bp) 
Reference: Kaether et al., 2004; Kaether et al., 2002 
PE d7 -PALP -WNF / pcDNA3.1/Zeo(+)
7106 bp
Amp(R)
Zeo(R)
PE delta7 -PALP -WN
SV40 pA
BGH pA
BGH reverse primer
CMV forward primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
EM7 promoter
T7 promoter
f1 origin
pUC origin
WNF->AAA
PALP->AAAA
EcoRI (953)
XhoI (3077)
Not I (2020)
Not I (2743)
 
Construction: PE Δ7 -PALP -WNF was generated from PE Δ7 -PALP using site directed mutagenesis. SP TM4 WNF-
>AAA 5’-ATTACTGTTGCACTCCTGATCGCGGCTGCTGGTGTGGTGGGAATG-3’; ASP TM4 WNF->AAA 5’-
CATTCCC ACCACACCAGCAGCCGCGATCAGGAGTGCAACAGTAAT-3’. 
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: PE Δ7 -WNF / pcDNA3.1 Zeo(+) 
Constructed by: Matthias Faßler, Christoph Kaether 
Plasmid: pcDNA3.1 Zeo(+) 
Insert: PS1-EGFP Δ7 with a WNF->AAA mutation in the TMD4 
Cloning sites: EcoRI, XhoI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII + NotI (4011 bp, 1749 bp, 723 bp, 623 bp) 
Reference: Kaether et al., 2004; Kaether et al., 2002 
PE d7 -WNF / pcDNA3.1/Zeo(+)
7106 bp
Amp(R)
Zeo(R)
PE delta7 -WN
SV40 pA
BGH pA
BGH reverse primer
CMV forward primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
EM7 promoter
T7 promoter
f1 origin
pUC origin
WNF->AAA
EcoRI (953)
XhoI (3077)
Not I (2020)
Not I (2743)
 
Construction: PE Δ7 -WNF was generated from PE Δ7 using site directed mutagenesis. SP TM4 WNF->AAA 5’-
ATTACTGTTGCACTCCTGATCGCGGCTGCTGGTGTGGTGGGAATG-3’; ASP TM4 WNF->AAA 5’-CATTCCC 
ACCACACCAGCAGCCGCGATCAGGAGTGCAACAGTAAT-3’. 
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: PE -PALP -WNF / pcDNA3.1 Zeo(+) 
Constructed by: Matthias Faßler, Christoph Kaether 
Plasmid: pcDNA3.1 Zeo(+) 
Insert: PS1-EGFP -PALP with a WNF->AAA mutation in the TMD4 
Cloning sites: EcoRI, EcoRI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII + NotI (4011 bp, 1749 bp, 838 bp, 723 bp, 295 bp) 
Reference: Kaether et al., 2004; Kaether et al., 2002 
PE -PALP -WNF/ pcDNA3.1/Zeo(+)
76 16  bp
Amp (R )
Zeo (R )
PE -PALP -W N FSV40 pA
B GH pA
B GH reverse pr imer
C MV fo rward p rimer
T7 p rimer
C MV p ro moter
SV40 ear ly promoter
bla promo ter
EM7 p ro moter
T7 p ro moter
f1 o rig in
pU C  o rig in
W NF ->AAA
PAL P->AAAA
EcoRI (9 53)
EcoRI (3554 )
NotI (2020)
NotI (274 3)
NotI (3581)
 
Construction: PE -PALP -WNF was generated from PE -PALP using site directed mutagenesis. SP TM4 WNF->AAA 
5’-ATTACTGTTGCACTCCTGATCGCGGCTGCTGGTGTGGTGGGAATG-3’; ASP TM4 WNF->AAA 5’-
CATTCCC ACCACACCAGCAGCCGCGATCAGGAGTGCAACAGTAAT-3’. 
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Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: PE -WNF / pcDNA3.1 Zeo(+) 
Constructed by: Matthias Faßler, Christoph Kaether 
Plasmid: pcDNA3.1 Zeo(+) 
Insert: PS1-EGFP with a WNF->AAA mutation in the TMD4 
Cloning sites: EcoRI, EcoRI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII + NotI (4011 bp, 1749 bp, 838 bp, 723 bp, 295 bp) 
Reference: Kaether et al., 2002 
PE -WNF/ pcDNA3.1/Zeo(+)
76 16  bp
Amp(R)
Zeo (R )
PE -W NFSV40 pA
B GH  p A
B GH  reverse primer
C MV fo rward  pr imer
T7 pr imer
C MV promo ter
SV40 early promoter
bla promoter
EM7 p romoter
T7 promo ter
f1 o rig in
pU C  or ig in
W NF ->AAA
EcoRI (9 53)
EcoRI (3554 )
NotI (2020)
NotI (274 3)
NotI (3581)
 
Construction: PE -WNF was generated from PE using site directed mutagenesis. SP TM4 WNF->AAA 5’-
ATTACTGTTGCACTCCTGATCGCGGCTGCTGGTGTGGTGGGAATG-3’; ASP TM4 WNF->AAA 5’-CATTCCC 
ACCACACCAGCAGCCGCGATCAGGAGTGCAACAGTAAT-3’. 
 
H
Appendix
 
Group: Membrane Trafficking of Proteins involved in Alzheimer´s Disease 
Head: Dr. Christoph Kather 
Tel +49 3641 656052 Email: mfassler@fli-leibniz.de
 
PLASMID DATA SHEET 
 
Name: Tac-RXR / pcDNA3.1/Zeo(+) 
Constructed by: Matthias Faßler 
Plasmid: pcDNA3.1/Zeo(+) 
Insert: fusion protein mTac and 36 AA from Kir 6.2 containing an RXR motif 
Cloning sites: BamHI, NotI, XbaI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII (3654 bp, 1749 bp, 491 bp) 
Reference: Zerangue et al., 1999 
mTac-RXR / pcDNA3.1/Zeo(+)
589 4  bp
mTac-RXR
Amp(R)
Zeo(R)
mTac
mTac-TMD
SV40 pA
BGH pA
BGH reverse primer
CMV forward primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
EM7 promoter
T7 promoter
f1 origin
pUC origin
RXR signal
C36 fragment of Kir6.2
BamH I (9 30)
NotI (174 7)
XbaI (1871)
 
Construction: mTac was amplified from a mTac construct from Christina Valkova. Primers SP mTac BamHI Kozak 5’-
GGATCCAGGACCATGGAGCCACGCTTGCTG-3’ (introducing BamHI and Kozak sequence) and ASP mTac NotI 
5’-TGCGGCCGCGATGGTTCTTCTGCT-3’ (removing STOP and introducing NotI) were used. PCR product was 
TOPO-TA cloned and excised with BamHI and NotI. Excised fragment was ligated into BamHI-NotI-cut CD4-RXR / 
Zeo.  
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PLASMID DATA SHEET 
 
Name: Tac-TM4 / pcDNA3.1 Zeo (+) 
Constructed by: Matthias Faßler 
Plasmid: pcDNA3.1 Zeo (+) 
Insert: mTac with PS1-TMD4 
Cloning sites: BamHI, XhoI 
Resistance: Amp , Zeo 
Diagnostic REN: PvuII (4032 bp, 1749 bp) 
Reference:  
mTac-TM4PS / pcDNA3.1/Zeo(+)
5781 bp
Amp(R)
Zeo(R)
mTac
PS-TMD4
SV40 pA
BGH pA
BGH reverse primer
CMV forward primer
T7 primer
CMV promoter
SV40 early promoter
bla promoter
EM7 promoter
T7 promoter
f1 origin
pUC origin
BamH I (9 30)
XhoI (1752)
 
Construction: mTac was ampflified from a mouse cDNA library (C. Valkova): SP mTac BamHI Kozak 5’-
GGATCCAGGACCATGGAGCCACGCTTGCTG-3’ (introducing BamHI site and Kozak sequence), ASP mTac STOP 
XhoI 5’-CTCGAGCTAGATGGTTCTTCTGCTC-3’ (introducing XhoI site). PCR product was TOPO-TA cloned and 
subsequently transferred to pcDNA3.1 Zeo (+). The Tac-TMD was swapped with the PS1-TMD4 using a standard 
protocol for PCR-based mutagenesis: SP mTac-TM4PS 5’-GCACTCCTGATCTGGAATTTTGGTGTGGTGGGAAT 
GATTTCCATTCAACACAGATGGAGGAAG-3’, ASP mTac-TM4PS 5’-ATTCCAGATCAGGAGTGCAACAG 
TAATGTAGTCCACAGCAACGTTCTCCATTGTGAGCACAAATG-3’.  
J
